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Like most major enzyme families, the M14 family of metallocarboxypeptidases
(MCPs) contains several pseudoenzymes predicted to lack enzyme activity and with
unknown molecular function. The genome of the yeast Saccharomyces cerevisiae encodes
only one member of the M14 MCP family, a pseudoenzyme named Ecm14 proposed to
function in the extracellular matrix. Ecm14 is found throughout ascomycete fungi, with a
group of related pseudoenzymes found in basidiomycetes. Although the prodomain of
Ecm14 can be cleaved in vivo and in vitro by endopeptidases, suggesting an activation
mechanism, no activity has been detected using standard carboxypeptidase substrates.
In order to examine the function of Ecm14 using an unbiased screen, a series of
synthetic lethal assays were performed. Because biochemical pathways typically involve

multiple key gene components, many of these key gene players provide redundancy if other
genes experience deleterious mutations. The synthetic lethal screen identifies novel
mutants whose survival depends on a particular gene of interest. Approximately 27,000
yeast colonies were screened; however, only twenty-two putative ecm14 synthetic lethal
mutants were identified. Further analysis showed many to be synthetic lethal with
auxotrophic marker (plasmid reporting and selection) genes and synthetic lethality due to
multiple mutations, suggesting that there are few, if any, single S. cerevisiae genes that
present synthetic lethal interactions with ecm14. Recent research by others suggests a role
for Ecm14 in processes such as vesicle-mediated transport and aggregate invasion, a fungal
process that has been selected against in modern laboratory strains of S. cerevisiae. Thus,
Ecm14 is likely an important, conserved, and “activatable” component of extracellular
processes that are not critical to most modern yeast strains.
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CHAPTER 1
INTRODUCTION
Genomes and the Evolution of Pseudoenzymes
Genomes contain a variety of components encoded in the ubiquitous four-base
language of nucleic acids. Although genes have traditionally been defined by their ability
to direct the translation of protein, many genes fundamentally lack all protein-coding
ability. These non-coding pseudogenes were once thought to be “junk DNA.” However,
numerous investigations have demonstrated that these non-coding DNA sequences indeed
play critical roles in directing protein synthesis and regulating gene expression through
their RNA products. Notable examples of these ubiquitous non-coding RNAs include
ribosomal RNA (rRNA), transfer RNA (tRNA), and microRNA (Pink et al., 2011).
Other genes, though coding for proteins, may not actually encode for the functions
that might be predicted based solely on their homology with other known and annotated
sequences. Although key active site substitutions in what appear to be enzyme-coding
genes might suggest a loss of catalytic activity, these substitutions might instead point
towards either a presently unknown and uncharacterized substrate or some novel
biochemical process.
It has been suggested that all major enzyme families across all kingdoms of life
likely contain inactive enzyme-homologues (Adrain & Freeman, 2012; Eyers & Murphy,
2016; Kwon et al., 2019; Ribeiro et al., 2019). In general, these pseudoenzymes are
characterized by highly conserved domains that appear structurally like those domains
found in otherwise catalytically active enzymes. However, substitutions of key active site
amino acids (or the absence of entire catalytic motifs altogether) in these conserved
1

domains suggest a loss of expected function in pseudoenzymes. From an evolutionary
perspective, enzymes might evolve an altered substrate specificity, an altered reaction to
be catalyzed, or, as in the extreme case of pseudoenzymes, a complete loss of catalytic
activity. However, the inclusion of these pseudoenzymes in our present understanding of
signal transduction networks and regulatory pathways is still relatively new and emerging
within the current paradigm of systems biology. Thus, pseudoenzymes have only recently
been considered as possible key players (Eyers & Murphy, 2016). In general, much work
remains in understanding these ubiquitous pseudoenzymes and evaluating their usefulness
as potential targets (or anti-targets) in the development of novel therapeutic agents.
The two most well documented pseudoenzymes are of the kinase and phosphatase
families (Eyers & Murphy, 2013; Reiterer et al., 2014). [In general, kinases attach
phosphate groups and phosphatases remove phosphate groups.] These inactive enzymehomologues have been demonstrated to function both as allosteric modulators (either by
activation or inhibition) and as non-catalytic competitors in signal transduction pathways
(Eyers & Murphy, 2016). Therefore, the present evidence suggests that pseudoenzymes are
likely functional, not as catalytically active enzymes, but rather as binding proteins that
only transiently interact with their substrates.
The central hypothesis for understanding the evolution of pseudoenzymes first
involves the genomic duplication of an “active” ancestral enzyme open reading frame
followed by subsequent mutation events that, while off-selection, can repurpose a domain
found in otherwise catalytically active enzyme (see Figure 1). These genetic copies,
though being functionally redundant, lack the traditional evolutionary pressure required to
maintain the otherwise catalytic motifs and phenotype(s) of their ancestral enzyme and,
2

thus, allow these genes to accumulate novel mutations (Bergthorsson et al., 2007; Eyers &
Murphy, 2016; Ohno, 1970).

Figure 1. The evolution of pseudoenzymes from active enzyme-homologues.
The evolution of pseudoenzymes might first (1) involves the genomic duplication
of an ‘active’ ancestral enzyme open reading frame followed by (2) subsequent
mutation events that, in turn, repurpose a domain found in otherwise catalytically
active enzyme in some potentially novel role.
The two primary models for understanding how genes (and, thus by proxy, their
protein or enzyme products) evolve novel functions through this broad mechanism of gene
duplication are 1) neofunctionalization and 2) subfunctionalization (Force et al., 1999;
Noda-Garcia & Barona-Gomez, 2013; Ohno, 1970). The accumulation of mutation events
in a duplicated gene over time typically results in the ubiquitous non-coding pseudogenes.
However, a divergence of function can occur when mutations either give rise to a novel
function or cause an otherwise promiscuous ancestral enzyme (one with several distinct
sub-functions) to further refine and specialize on a sub-function.
Catalytic motifs are defined in part by the presence of specific active site residues
that catalyze some specific biochemical reaction(s). However, these motifs are also defined
by their ability to interact with very specific ligands in potentially non-catalytic ways.
3

Reiterer et al. (2014) suggested that at least some active enzymes might have paradoxically
evolved from pseudoenzymes. However, in the absence of selective pressures to maintain
the catalytic motif in these duplicated genes, evolution is allowed to further tweak the noncatalytic function of these pseudoenzymes and, in turn, cause their sequences to further
deviate over time from their original ancestral sequences.
Although previous investigations involving pseudoenzymes have suggested
possible non-catalytic functions, it has been suggested that even catalytically active
enzymes too might be able to perform these novel, unexpected secondary functions (socalled promiscuous or “moonlighting” enzymes) (Jeffery, 2003). Therefore, both active
enzymes and their inactive homologues might share these previously uncharacterized and
noncatalytic roles. Because the structural motifs of active enzymes are inherently
predisposed to facilitating very specific substrate-binding interactions, these structures
serve as ideal candidates to being evolutionarily repurposed and reused in some noncatalytic capacity (Eyers & Murphy, 2016). Therefore, studies involving pseudoenzymes
can potentially inform our understanding of even catalytically active enzymes in general
by suggesting possible functions beyond just the prototypical native catalytic function.
One possible model for understanding the function of pseudoenzymes that have
been implicated in substrate binding and localization is the rhomboid protease family,
which includes several active members as well as inactive enzyme-homologues. [Proteases
and proteolysis are discussed in more detail in a subsequent introductory section.] Active
rhomboid proteases function in the proteolysis of transmembrane proteins and the
subsequent release of signaling molecules from a variety of cellular organelles (Lemberg,
2011). Active rhomboid proteases have been demonstrated to function in the epidermal
4

growth factor receptor signaling pathway in C. elegans, Drosophila, and mammalian cells
(Adrain & Freeman, 2012; Blobel et al., 2009; Dutt et al., 2004).These active proteases cut
membrane-bound growth factor precursors and liberate active growth factors which in turn
bind to receptors on neighboring cells and initiate cascades of growth signals. In contrast,
several inactive rhomboid pseudoproteases (e.g. Derlin-1 and iRhoms) have adopted novel,
non-traditional function that seem to complement the function of active rhomboid
proteases: they bind to and help destabilize substrate proteins targeted by active rhomboid
proteases in the endoplasmic reticulum-associated degradation of misfolded proteins
(Adrain & Freeman, 2012; Greenblatt et al., 2011; Zettl et al., 2011).
How these pseudoenzymes adapt and evolve to fill novel biological and
biochemical niches in general remains to be fully understood. The broad classification of
putative pseudoenzymes is largely based on batch in silico sequence comparisons against
sequences of known catalytic domains that have a wealth of experimental validation in the
literature. In other words, such comparisons only work well when using catalytic source
sequences with very well-defined mutations that demonstrably nullify the expected
catalytic activity. However, this type of comparison does suggest probable knowledge gaps
and the inescapable possibility that many enzymes are actually erroneously classified as
catalytically active in online enzyme databases (or, conversely, many pseudoenzymes
incorrectly classified as catalytically inactive) due to a fundamental lack of targeted
experimental evidence (Eyers & Murphy, 2016; Ribeiro et al., 2019).
Because pseudoenzymes are thought to be present in all major enzyme families
across all domains of life, the majority of these pseudoenzymes largely remain either
unidentified, misidentified, or entirely uncharacterized. For instance, adequately validating
5

a complete lack of catalytic function fundamentally requires that all possible substrates be
known—a lofty and seemingly insurmountable requirement (Ribeiro et al., 2019).
Furthermore, the obscure functional nature of these pseudoenzymes makes them inherently
difficult to associate with a phenotype. However, a quantifiable phenotype is
fundamentally needed in order to systematically study the biochemical and biological
implications of the key active site substitutions found in these pseudoenzymes. Once a
quantifiable phenotype is either identified or engineered, a series of targeted experiments
can be performed that selectively interrogate each of the key active site substitutions and
individually assess their necessity and/or usefulness. One goal of this study is to design
such a targeted approach to the investigation of a suspected pseudoenzyme found in the
baker’s yeast Saccharomyces cerevisiae.
Although targeted experiments focused on the biochemical and biological nature
of pseudoenzymes remain to be particularly challenging, there are several key strategies
and techniques that can be used to build a general case for function (or the lack thereof).
These strategies might include sequence comparison and protein homology modeling,
classifying and grouping novel genes as being involved in broad functional classes,
phylogenic tree analysis and visualization, enzymatic prodomain cleavage followed by
Edman N-terminal degradation sequencing, enzyme activity assays, and in vivo protein
localization and gene expression assays.
Although prior investigations have demonstrated that several pseudoenzymes have
also adopted novel, non-catalytic functions, much work remains in order to accurately
identify, clarify and characterize the function of these inactive enzyme-homologous
(Greenblatt et al., 2011; Pils & Schultz, 2004; Zettl et al., 2011).
6

Saccharomyces cerevisiae as a Model Organism
One flexible model organism for studying the biochemical and biological nature of
pseudoenzymes is the ascomycete fungi Saccharomyces cerevisiae (see Figure 2).
Because the yeast S. cerevisiae has an extensive history both as a model organism and in
the baking and brewing industries, many well-demonstrated techniques and tools already
exist that make its genetic manipulation both inexpensive and robust.

Figure 2. A budding haploid S. cerevisiae yeast cell.
A micrograph of a budding haploid S. cerevisiae yeast cell. The large central
vacuole in the parent yeast cell can be observed poking into the daughter bud.
As a eukaryotic organism, yeast are capable of reproducing sexually and exhibit an
alternation of generations between diploid, spore-producing sporophytes and haploid,
gamete-producing gametophytes. Additionally, humans and yeast share over one thousand
orthologous genes (~23% homologous genes to humans) (Laurent et al., 2016; Liu et al.,
2017). Therefore, these features together make the yeast S. cerevisiae a prime candidate
for high-throughput gene function studies that require both precise genetic manipulation
and sexual reproduction capabilities (qualities that are of critical importance to this
investigation in particular).
7

Yeast have considerably simpler genomes than those of higher order eukaryotes.
Like bacteria, yeast can readily be transformed with plasmid DNA (Hinnen et al., 1978).
These plasmids can either replicate independently (sometimes even behaving like
miniature chromosomes) or integrate directly into the yeast genome, sometimes tagging or
even deleting endogenous genes via homologous recombination (Duina et al., 2014). The
capability to selectively target, tag, and disrupt endogenous genes with a high degree of
precision has made yeast a preeminent model organism. Furthermore, the sophisticated
portfolio of genomic and molecular tools available to yeast biologists further qualify S.
cerevisiae as a premier experimental subject.
Chromosome III (315-kb) of the yeast S. cerevisiae genome was the first
chromosome from any organism to be completely sequenced (Oliver et al., 1992). In
addition to the monumental achievements related to chromosome III, the prevalence of S.
cerevisiae in both commercial industry and human health likely motivated the worldwide
collaboration to sequence the remaining 15 chromosomes (Goffeau et al., 1996). As such,
the yeast genome was the first eukaryotic genome to be entirely sequenced. To date, the
yeast genome has been thoroughly sequenced many times over, using every major
generation of whole-genome sequencing technology including Sanger, Illumina®,
PacBio®, and Oxford Nanopore® (Cherry et al., 2012; Engel et al., 2014; Goodwin et al.,
2015; Matheson et al., 2017).The Saccharomyces Genome Database (SGD) is the
prominent, online database and curated search tool for exploring the wealth of yeast
genome data (Cherry et al., 2012). Whole-genome sequencing of the yeast S. cerevisiae
genome is significant to this investigation.

8

Characteristics of the Fungal Kingdom
The Kingdom Fungi is a highly diverse group of heterotrophic eukaryotes that can
obtain nutrients either as saprophytes or as symbionts (e.g. with plant roots as a
mycorrhiza). Members of the Kingdom Fungi can range from the unicellular budding
yeasts (e.g. S. cerevisiae) and aquatic chytrids to larger mushrooms and even the colossal
Armillarians. For example, a single individual of A. bulbosa, with an estimated biomass of
10,000 kg, has been identified in a northern Michigan hardwood forest (Smith et al., 1992).
This single clonal individual spans nearly 40 acres. Even larger Armillarians have been
identified in the Pacific Northwest (Ferguson et al., 2003). In general, only about 100,000
fungal species have been identified to date. However, conservative estimates suggest that
the fungal kingdom likely contains between 2.2 and 3.8 million species (Hawksworth &
Lücking, 2017). Thus, only about 3-8% of fungal species have been named so far.
Unlike members of the other three eukaryotic kingdoms (Animalia, Plantae, and
Protista), fungi characteristically contain cell walls that utilize chitin polymers.
Additionally, chitin is the primary structural component in the exoskeleton of arthropods.
Additionally, members of the Kingdom Plantae also contain cell walls. However, the major
carbohydrate in plant cell walls is cellulose. Cellulose consists of linear chains of repeating
β-1,4-linked D-glucose monomers. In contrast, glucose is replaced by N-acetylglucosamine
monomers in chitin nanofibrils. Chitin plays an important role in the structure of fungal
cell walls. In contrast to the more elastic β-glucan fibers, chitin confers the bulk of the
wall’s rigidity and its ability to withstand both chemical and physical abuse (Fesel &
Zuccaro, 2016). This resiliency stems in part from the insolubility of chitin in water. [Yeast
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cell wall biology is of interest in this study and is discussed in more detail in a subsequent
introductory sub-section.]
Members of the Kingdom Fungi exhibit an alternation of generations between
diploid, spore-producing sporophytes and haploid, gamete-producing gametophytes. As a
member of the Kingdom Fungi, S. cerevisiae, too, exhibits this phenomenon. However, the
gametophyte generation typically predominates. During both stages, the yeast S. cerevisiae
grows via mitotic budding, a type of asexual reproduction. However, meiosis produces
haploid spores from mature diploid sporophytes in response to stress during the early stages
of sporulation (Neiman, 2011). Haploids are generally more efficient at reproducing and
surviving. The metabolic trade-offs between these two ploidy stages suggest an adaptive
function of meiosis and, thus, an underlying survival mechanism in response to stress
conditions (Zörgö et al., 2013).
Although the yeast S. cerevisiae can reproduce sexually, outcrossing is generally
quite rare due to both mating types being produced in such close proximity within a single
ascus (Ruderfer et al., 2006). Therefore, the rarity of outcrossing suggests that meiosis is
conserved, not as a means of introducing genetic variation, but rather as a means of
enhancing phenotypic stability and repairing DNA following periods of prolonged
metabolic stress (Birdsell & Wills, 2003). This inherent stability of the fungal genome
further qualifies S. cerevisiae as a prime model organism.
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Diversity of the Ascomycete Fungi
The ascomycetes represent the largest phyla of the Kingdom Fungi and consists of
over 64,000 species (Hawksworth & Lücking, 2017). The unifying characteristic of
Ascomycota is the presence of an ascus, a reproductive sac-like structure that contains the
haploid ascospores (Neiman, 2005). The meiotic divisions during ascus formation do not
culminate in cytokinesis. Instead, the meiotic nuclear products are individually captured
and encased in new cell membrane and wall within the now anucleate ascus ‘sac.’ As a
member of Ascomycota, S. cerevisiae too produce asci during sexual reproduction.
However, the haploid stage predominates in domesticated yeast species.
The phylum Ascomycota is subdivided into the three distinct subphyla
Pezizomycotina, Saccharomycotina, and Taphrinomycotina (Eriksson & Winka, 1997).
The subphyla Pezizomycotina is the largest subdivision of Ascomycota and contains over
30,000 named species (Kirk et al., 2001). Pezizomycotinas are characterized by a
predominately filamentous morphology and represent most of the fruiting ascomycetes.
Pezizomycotinas can be found in both aquatic and terrestrial environments and as
symbionts (e.g. mycorrhizae and lichens) and as pathogens (Spatafora et al., 2006;
Sugiyama et al., 2006). Pezizomycotinas play significant roles in both human health and
disease. For example, Penicillium rubens (or P. chrysogenum) is infamously known for its
production of penicillin, one of the most widely used antibiotic agents, and Tolypocladium
inflatum for its production of cyclosporin A, a potent immunosuppressant drug (Houbraken
et al., 2011; Wenger, 1984). The World Health Organization considers both penicillin and
cyclosporin A to be essential drugs within the context of even the most basic health-care
systems. Finally, the pezizomycotina Neurospora crassa, named for the distinct axon-like
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morphology of the spores, is a popular model organism in biochemistry, genetics, and
molecular biology. The draft sequence of N. crassa was reported in 2003 and has since
been thoroughly characterized and refined (Galagan et al., 2003).
The subphylum Saccharomycotina consists of the classical ascomycete ‘yeasts’
including Candida albicans, Ashbya gossypii, and Saccharomyces cerevisiae (Eriksson &
Winka, 1997). Although many members of this subphylum have tremendous commercial
applications, some are indeed pathogenic and play significant roles in human health and
disease. For instance, infection by C. albicans is the leading cause of mycosis-related death
in the United States (Pfaller & Diekema, 2007). Although C. albicans is usually a
commensal resident of the human gastrointestinal tract, immunocompromised and/or
genetically predisposed individuals are especially susceptible to developing deadly
candidiasis infections (Martins et al., 2014). A. gossypii has been the primary industrial
commercial producer of riboflavin (vitamin B2) for many decades (Aguiar et al., 2015).
Finally, the subphylum Taphrinomycotina consists of a diverse variety of taxa
including

Neolectomycetes,

Pneumocystidomycetes,

and

Schizosaccharomycetes

(Eriksson & Winka, 1997). The Neolecta species are characterized by fleshly yellowishorange unbranched (or branched) fruiting bodies (Landvik et al., 2003). A notable member
of the Pneumocystidomycetes is Pneumocystis jirovecii, a commensal resident in the
human lungs. Similar to candidiasis infections, P. jirovecii can cause deadly Pneumocystis
pneumonia in immunocompromised individuals (Aliouat-Denis et al., 2008). Finally,
although similar to S. cerevisiae, the Schizosaccharomycetes reproduce exclusively via
medial fission, hence the nickname ‘fission yeast’ (Hoffman et al., 2015).
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The Biology and Ecology of Saccharomyces cerevisiae
The ability to maintain and propagate monoclonal strains of Saccharomyces
cerevisiae have allowed scientists to study the genetics of what is effectively a few single
individuals and, thus, rigorously characterize and document a few well-studied strains
(Greig & Leu, 2009). Although select yeast strains are commonly employed in a variety of
commercial processes such as baking/brewing and as a model organism in the laboratory,
it remains unclear whether S. cerevisiae truly exists as a naturally occurring ‘wild’ species
(Duina et al., 2014; Greig & Leu, 2009). Perhaps the distribution of S. cerevisiae in nature
is, instead, largely artificial and simply the result of domestication.
In these tightly controlled and unnatural domesticated contexts, yeasts have very
little reason, if any, to adapt and, as such, very little is known about how S. cerevisiae
responds to both intra- and interspecific competition within these “natural” microbial
communities (Boynton & Greig, 2014; Jouhten et al., 2016). This significant knowledge
gap severely handicaps the work towards a contextually accurate understanding of the
relationship between the ecology, evolution, and genetics of S. cerevisiae. Therefore, the
ecology of S. cerevisiae is vastly different from other ascomycetes in that this ecology is
likely the result of domestication and, thus, is largely man-made.
Genomic analyses have suggested that S. cerevisiae originated ‘out-of-China’
(Peter et al., 2018). This Chinese origin coincides with some of the earliest evidence of
alcoholic drinks in recorded human history. Saccharomyces paradoxus, the closest known
relative of S. cerevisiae, can be found as a commensal resident on the bark and leaves of
deciduous trees throughout the northern hemisphere (Boynton & Greig, 2014; Greig &
Leu, 2009). However, the bark and leaves of these deciduous trees are notably low-sugar
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substrates. In contrast, S. cerevisiae most commonly grows on distinctly high-sugar
substrates (e.g. the skin of grapes) and is well known for its efficiency in fermenting sugars
to ethanol (Duina et al., 2014). Fortunately, S. paradoxus remains to be marred by the
pressures of domestication and, thus, serves as a potential surrogate for studying and
understanding the ecology, evolution, and genetics of these hypothetical ‘wild’ yeast
populations (Dunham & Louis, 2011; Greig & Leu, 2009).
In general, Saccharomyces species share similar biochemical phenotypes and
morphologies (Boynton & Greig, 2014). Although S. cerevisiae and S. paradoxus are both
mesophilic, the ideal temperature for S. paradoxus is slightly lower than that of S.
cerevisiae. Furthermore, the biogeographical distribution of four distinct S. paradoxus
strains throughout the northern hemisphere suggest that these yeasts can adapt to distinct
climatic conditions and, thus, likely contain temperature-dependent genetic components
(Leducq et al., 2014).
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Biology of the Yeast Cell Wall
The cell wall of the yeast Saccharomyces cerevisiae is a dynamic extracellular
structural matrix that consists of several polysaccharide-based polymers including
β-glucans (polymers of uridine diphosphate-N-glucose, UDP-Glc), chitin (a polymer of
uridine diphosphate-N-acetylglucosamine, UDP-GlcNAc), and mannoproteins (proteins
glycosylated with mannose) (Lesage & Bussey, 2006). The ability to regulate the
biosynthesis and remodeling of the cell wall plays a critical role in maintaining cellular
integrity during a variety of cellular events (i.e. division, growth, and mating) and in
response to both environmental and metabolic stress conditions (Popolo et al., 2001). Thus,
the biosynthesis and the remodeling of the cell wall are tightly controlled processes and
critical to the survival of the yeast.
In general, the cell wall in fungi and plants creates a strong, polysaccharide-proteinbased framework by which individual cells can act as structural bricks within some larger
framework or body plan (Somerville et al., 2004). However, this role is irrelevant in
unicellular fungi such as the yeast S. cerevisiae. In addition to these roles in maintaining
cellular shape and protecting against stressful conditions, the cell wall is also involved in
regulating the influx and efflux of water by osmosis by allowing cells to elastically expand
or contract in response to changes in extracellular osmolarity (Klis et al., 2006). Although
there is much inter-kingdom diversity in both cell wall composition and structure, the
underlying secretory mechanisms and pathways involved in eukaryotic cell wall
biosynthesis are, for the most part, highly conserved (Lesage & Bussey, 2006). In the yeast
S. cerevisiae, the cell wall consists of approximately 85% polysaccharides and 15%
proteins by mass (Nguyen et al., 1998). Furthermore, the cell wall can account for
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approximately one-third of the dry mass of the yeast S. cerevisiae (Aguilar-Uscanga &
Francois, 2003).
The yeast cell wall primarily consists of an inner chitin/β-glucan matrix layer and
an outer layer of mannoproteins. The space between the yeast cell wall and plasma
membrane is traditionally referred to as the periplasmic space. Two distinct varieties of βglucans are found in yeast. These include β-1,3-glucans, which form the primary
polysaccharide backbone, and shorter β-1,6-glucans, which form elongated, interbackbone branches (Lesage & Bussey, 2006). This branching network of 1,3 and 1,6 βglucans serves to both cross-link chitin polymers via β-1,4 glycosidic linkages and provide
an overall spring-like resistance to the cell wall (Klis et al., 2006). Furthermore, the relative
amounts of β-1,3 and β-1,6-glucans vary depending on the morphological state of the yeast
(Magnelli et al., 2002). β-1,3-glucans are synthesized and translocated to the periplasmic
space by β-1,3-glucan synthase, a transmembrane enzyme. This enzyme synthesizes β-1,3glucan from UDP-Glc, a cytoplasmic precursor, and extrudes newly synthesized linear β1,3-glucan strands into the periplasmic space where they are incorporated into the cell wall.
β-1,3-glucan synthase consists of two catalytic subunits (encoded by FKS1 and GSC2) and
one regulatory subunit (encoded by RHO1). Rho1 integrates a variety of signals from
sensors in both the cell wall and the intracellular actin cytoskeleton (Lesage & Bussey,
2006). However, much work remains in fully characterizing and understanding the central
role of Rho1 in modulating β-1,3-glucan synthase activity.
Chitin plays an important role in the maintenance of the yeast cell wall. In contrast
to the more elastic β-glucan matrix, chitin confers the bulk of the walls rigidity and its
ability to withstand both chemical and physical abuse (Fesel & Zuccaro, 2016). This
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resiliency stems in part from the insolubility of chitin in water. Chitin is predominantly
found close to the plasma membrane. Like β-1,3-glucan synthase, two transmembrane
chitin synthases (Chs2 and Chs3) synthesize chitin by modifying and adding cytoplasmic
UDP-GlcNAc precursors to the growing chain within the periplasmic space (Lesage &
Bussey, 2006). These chitin synthases are activated at different times. Chs2 predominates
during cytokinesis and Chs3 predominates during initial bud formation.
The fungal cell surface and cell wall play critical roles in budding, mating, and cell
fusion (Lussier et al., 1997). As such, the cell surface and cell wall vary immensely in
composition, shape, and structure throughout the fungal life cycle.

17

Calcofluor White: An Inhibitor of the Cell Wall
Calcofluor white (fluorescent brightener 28) is a fluorescent stain that associates
strongly with chitin and cellulose (both structural polymers comprised of polysaccharides)
and is commonly used in the detection of fungal, algal, and plant cell walls (Harrington &
Raper, 1968; Herth & Schnepf, 1980; Nagata & Takebe, 1970). Calcofluor white has also
been used to identify chitin in chitin-containing organisms such as arthropods and certain
sponges (Ehrlich et al., 2013).
The active fluorochrome is the disodium salt of a highly conjugated stilbene
derivative (Harrington & Raper, 1968) (see Figure 3). Using ultraviolet and electron
microscopy, Herth and Schnepf (1980) demonstrated that calcofluor white tightly
associates via hydrogen bonding parallel to the longitudinal axis of chitin and cellulose.
However, this strong association between calcofluor white and the longitudinal axis of
chitin and cellulose can impair the nucleation and elongation of these polymers.

Figure 3. The molecular structure of calcofluor white.
The active fluorochrome of calcofluor white fluoresces when it associates with β1,4 and β-1,3 glycosidic linkages found in cellulose and chitin, the primary
structural component of plant and fungal cell walls, respectively. MW=960.95
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Calcofluor white has been shown to negatively affect endogenous chitin
polymerization and remodeling of the fungal cell wall. Roncero and Duran (1985) noted
that a 2% calcofluor white solution dramatically inhibits the growth of wild-type S.
cerevisiae. In addition to complete growth inhibition at high concentrations, Roncero and
Duran (1985) observed varying responses in S. cerevisiae to differing calcofluor white
concentrations. For instance, certain yeast strains were not appreciably affected by
calcofluor white concentrations below 15 μg/ml. However, at intermediate concentrations
with other strains, Roncero and Duran (1985) observed budding yeast failing to separate
by producing distinctly abnormal multicellular aggregates and, thus, resulting in a dramatic
decreased cell growth rate.
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The Diversity of Peptidases and Proteolysis
Proteases (peptidases) are enzymes that catalyze the post-translational (and usually
irreversible) hydrolysis of peptide bonds covalently joining adjacent amino acids in
substrate polypeptide chains. In general, these enzymes are classified according to the
underlying mechanism of peptide bond hydrolysis. The MEROPS database represents the
de facto standard in the field for classifying these diverse enzymes, their substrates and
their inhibitors (Rawlings et al., 2018). For example, aspartic (A-), glutamic (G-), and
metallo (M-) type peptidases typically employ a one-step catalysis; and cysteine (C-),
serine (S-), and threonine (T-) peptidases typically employ a two-step catalysis.
In one-step catalysis, an acidic amino acid (i.e. aspartate or glutamate) or a divalent
cation (i.e. zinc) first polarizes a water molecule which then, in turn, directly catalyzes the
hydrolysis of some targeted peptide bond via a classical nucleophilic attack and, thus,
liberates two cleavage products. However, a two-step protease is first transiently bound to
the targeted peptide covalently which, in turn, destabilizes the original peptide bond and
displaces one cleavage product. However, the second cleavage product remains covalently
linked to the protease until a water molecule can eventually perform a classical nucleophilic
attack on this transient protease-substrate bond and, thus, liberate the second cleavage
product.
Carboxypeptidases are proteases that more specifically catalyze the hydrolysis of
carboxy-terminal (c-terminal) amino acids from substrate polypeptide chains (GomisRuth, 2008). As a peptidase, carboxypeptidases too are classified according to the
conventional MEROPS enzyme types (A-, C-, G-, M-, S-, T-, or U-) based on their
structure and underlying catalytic mechanism (Rawlings et al., 2018).
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The M14 Metallocarboxypeptidase Family
Metallocarboxypeptidases (MCPs) or M-type carboxypeptidases are of interest in
this study. Like other proteases, the catalytic activity of MCPs has been implicated in a
variety of post-translational processing pathways, such as the processing of pro-hormones
and neuropeptides (Arolas et al., 2007). One notable family of MCPs is the human M14
family that contains 21 catalytically active members and four members predicted to be
catalytically inactive (Pascual et al., 1989; Petrera et al., 2014; Reznik & Fricker, 2001;
Tan et al., 1993) (see Figure 4).

Figure 4. The human M14 metallocarboxypeptidase family.
The human M14 family contains 21 catalytically active members and four members
predicted to be catalytically inactive (*). The protein coded by ECM14 in
Saccharomyces cerevisiae is homologous to human CPA1 (**).
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Members of the human M14 family have been implicated in a variety of
physiological functions and disease pathways. Three notable active members of the M14
family are carboxypeptidase B2 (CBP2/TAFI/), carboxypeptidase E (CPE), and cytosolic
carboxypeptidase 1 (CCP1/Nna1/AGTPBP1). These three members briefly illustrate the
functional diversity of this enzyme family.
1. Carboxypeptidase B2 (CBP2/TAFI/CPU) functions in blood plasma as an
inhibitor in the fibrinolytic pathway (Eaton et al., 1991). Active plasmin alone
is a very powerful hydrolyzer of fibrin, the fibrous structural protein involved
in blood clot formation (Ezihe-Ejiofor & Hutchinson, 2013). CPB2 is
synthesized by the liver as the zymogen proCPB2, a catalytically inactive
precursor. Active CPB2 inhibits the fibrinolysis pathway by preferentially
cleaving c-terminal lysine residues from fibrin, making fibrin less favorable for
degradation by activated plasmin. Because the effect of active CPB2 is
complemented with fibrin cross-linking and stabilization by coagulation factor
XIII, a CPB2-deficiency alone does not lead to grossly impaired hemostasis
(Nagashima et al., 2002). However, deficiencies in both CPB2 and coagulation
factor XIII result in premature clot lysis and overall hemostasis dysregulation.
2. Carboxypeptidase E (CPE/CPH) plays a ubiquitous role in the biosynthesis
of nearly all neuropeptides and peptide hormones within the human body
(Fricker, 2018). These peptides include insulin, vasopressin, oxytocin, and the
enkephalins. Mice homozygous for the fat spontaneous mutation (Cpefat/Cpefat)
exhibit a variety of endocrine disorders including hyperglycemia, infertility,
insulin resistance, and obesity (Naggert et al., 1995). Although CPE mutations
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within the human population are not common, a truncating mutation has been
documented in a morbidly obese female with type II diabetes mellitus (Alsters
et al., 2015).
3. Cytosolic carboxypeptidase 1 (CCP1/Nna1/AGTPBP1) has been implicated
in the deglutamylation (a post-translational modification) of tubulin during a
variety of cellular events including axonal regeneration, axogenesis,
dendritogenesis, and the synthesis and maintenance of the ciliary/flagellar
axoneme (Kalinina et al., 2007; Otazo et al., 2013). Defective tubulin
deglutamylation is responsible for neurodegeneration in the classical Purkinje
cell degeneration (pcd) mouse, which lacks functional CCP1. These mice
exhibit adult-onset degeneration of cerebellar Purkinje neurons, olfactory bulb
mitral neurons, retinal photoreceptors, and select thalamic neurons.
Catalytically active MCPs of the M14 family characteristically contain six
conserved active site residues: H/His69 (histidine), E/Glu72 (glutamate) R/Arg127
(arginine), R/Arg145, H/His196, and E/Glu270 (glutamate) (Auld, 2004; Lyons & Fricker,
2011). [These numbers represent the positions of each residue in the mature polypeptide
sequence of the prototypical carboxypeptidase, CPA1, from Bos taurus.]
H69, E72, and H196 play roles in coordinating with a required zinc ion; R127 and
R145 are involved in the binding of c-terminal carboxylate groups; and E270 functions as
a catalytic general base (see Figure 5). Substitutions at any of these critical positions likely
results in a loss of traditional carboxypeptidase-like activity.
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Figure 5. The active site of the prototypical carboxypeptidase from Bos taurus.
The active site of an metallocarboxypeptidase must contain two arginines (R127
and R145) to bind the substrate c-terminus (shown in yellow), a glutamate (E270)
to perform acid-base hydrolysis, and three other residues (H69, E72, and H196) for
coordination with a zinc ion (gray sphere). The dipeptide glycyl-L-tyrosine
substrate is shown in the active site (shown in yellow). Only the carboxypeptidase
domain is shown. Model generated using PyMOL (PDB ID 3CPA).
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ECM14: A Fungal Pseudopeptidase
The yeast Saccharomyces cerevisiae genome contains ≈6,000 genes (≈5,000 nonessential and ≈1,000 essential) (Winzeler et al., 1999). [Non-essential genes are defined as
being those that can be singularly disrupted without causing significant harm to an
organism.] Of these genes, only one gene, ECM14, codes for a member of the M14 family
of MCPs. The protein coded by ECM14 is homologous to human CPA1 (one of the 21
catalytically active members of the M14 MCP family) (see above Figure 5). Although
many amino acid residues are conserved between fungal Ecm14 and human CPA1,
multiple

substitutions in the presumed active site of Ecm14 seem to indicate a loss of

traditional carboxypeptidase-like activity (Idowu et al., 2016) (see Figure 6, Figure 7).

Figure 6. Comparison of Ecm14 with bovine CPA1 indicates that Ecm14 is likely
an inactive member of the M14 carboxypeptidase family.
Ecm14 sequences from each of the three subphyla of Ascomycota are shown
compared to B. taurus CPA1. The predicted cleavage sites for signal peptidase are
shown in green. Possible sites at which a trypsin-like endopeptidase might cut to
remove the prodomain are shown in pink. Critical active site amino acids are shown
in blue, with the corresponding numbering from bovine CPA1 above.
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Figure 7. Ecm14 is similar to other metallocarboxypeptidases.
The tertiary structure of Ecm14 was modeled using SWISS-MODEL and an X-ray
crystal structure for human CPA1 (PDB ID 4UF4). The catalytic domain is shown
in blue and the prodomain in green. Endopeptidase cleavage sites for trypsin are
shown in pink and for chymotrypsin in yellow. Models were generated using
PyMOL. The resulting Ramachandran plot is also shown (bottom right).
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At least within the context of routine laboratory growth conditions, ECM14 is a
non-essential gene in the yeast S. cerevisiae genome (Winzeler et al., 1999). However, the
conservation of ECM14 in the genome of ascomycete fungi, but not in other fungal phyla,
suggests that Ecm14 does have some, albeit presently unknown, function (see Figure 8).

Figure 8. Ecm14 is conserved in Ascomycota, but not in other fungal phyla.
CPA1-like fungal proteins fall into three broad categories based on active site
residues: standard CPA/CPB proteins containing all expected active site residues,
with representatives from all subphyla of fungi (blue box), basidiomycete CPA
proteins containing expected active site residues with the exception of 5 closely
aligned proteins from 5 different species containing R127Y, H196R, and E270H
substitutions (green box), and Ecm14-like proteins found only in ascomycetes and
defined by the presence of N144D and E270K substitutions.
Prodomain cleavage is an essential feature of many catalytically active peptidases.
For example, the model zinc protease, CPA1, is synthesized within the rough endoplasmic
reticulum of pancreatic centroacinar cells as the zymogen proCPA1, a catalytically inactive
precursor. This zymogen is secreted in response to stimulation of the pancreas by
cholecystokinin (CCK), a digestive hormone. Once in the duodenum, proteolytic cleavage
of the N-terminal prodomain (a 95-aa regulatory domain) liberates the catalytically active
carboxypeptidase domain (see above Figure 7). Because cleavage of a prodomain is
typically associated with activation in peptidases, retention of prodomain cleavage in
Ecm14 likely suggests some underlying function to be regulated.

27

Previous work by Idowu et al. (2016) has demonstrated that both trypsin and
chymotrypsin are able to cleave the prodomain of Ecm14 in vitro. Edman N-terminal
degradation sequencing was performed by The Synthesis & Sequencing Facility at Johns
Hopkins University (Baltimore, M.D.) in order to identify the location of these
endopeptidase cleavage sites (see above Figure 7). Furthermore, previous work by Schott
(2015) suggests that Ecm14 might be able to compete with active carboxypeptidases in
vitro by binding and protecting c-terminal amino acid residues of potential substrates.
Although this previous work has preliminarily suggested some activity of Ecm14
in vitro, very little is known about the in vivo implications of the key amino acid
substitutions in the presumed active site of Ecm14 (and pseudoenzymes in general).
However, the present evidence suggests that Ecm14 is likely functional; not as a
catalytically active enzyme, but rather as a binding protein that transiently interacts with
other protein substrates and, thus, influences the intracellular localization and/or fate of
these protein substrates.
The obscure functional nature of pseudoenzymes in general makes them inherently
difficult to associate with a phenotype. Although previous studies have suggested several
phenotypes for ECM14, the potential of these phenotypes for both reproducibility and
quantification remains to be fully understood. However, a reproducible and readily
quantifiable phenotype is fundamentally needed in order to systematically study the
biochemical and biological implications of the key amino acid substitutions of
pseudoenzymes in general.
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Potential Phenotypes of ECM14
In a genome-wide screen focused on characterizing yeast genes involved in cell
wall architecture and remodeling, Lussier et al. (1997) identified Ecm14 as a possible
player in this broad functional classification. Understanding the impact of calcofluor white
on chitin polymerization and cell wall biosynthesis, Lussier et al. (1997) began by initially
screening for any altered sensitivity to calcofluor white in transposon-mutagenized yeast
cells. Ram et al. (1994) first postulated that exposure to calcofluor white amplifies the
effect of mutations in genes specifically involved in cell wall architecture and remodeling.
Additional supplemental screens were used to further characterize the impact of each
mutated gene on a variety of phenotypes known to be related to cell wall biology. In
addition to ECM14, at least 81 other genes in the yeast S. cerevisiae genome were
identified, that when mutated, confer at least some modified sensitivity to calcofluor white
(Lussier et al., 1997). An altered cell wall hexose composition (an increased mannose:
glucose ratio) and a hypersensitivity to the antifungal compounds Hygromycin B and
Papulacandin B were also observed in ecm14 mutants.
In a genome-wide screen, Hillenmeyer et al. (2008) systematically subjected every
non-essential gene knockout yeast strain to a variety of different chemicals and identified
several potential fitness defects associated with ecm14 deletion. These fitness defects
included a reduced sensitivity to paraquat, mercury chloride, and lithium chloride.
However, Idowu et al. (2016) were unable to clearly replicate these results. It is theorized
that a disturbed or weakened cell wall is simply not able to withstand drug or chemical
concentrations as effectively as the more robust cell wall of wild-type yeast cells.
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Therefore, a disturbed or weakened cell wall might also explain the fitness defects observed
by Hillenmeyer et al. (2008) and Lussier et al. (1997).
Finally, Schoner et al. (2008) identified arp1 ecm14 double mutants as potentially
being inviable—a case of synthetic lethality. [Actin-related protein 1 (Arp1) serves as a
filamentous core backbone in the dynactin complex, which functions in nuclear migration
during mitosis (Igarashi et al., 2005). Additionally, Arp1 plays an essential role in ensuring
the completion of cell wall remodeling prior to mitotic initiation.] However, like the fitness
defects observed by Hillenmeyer et al. (2008) and Lussier et al. (1997), attempts to
replicate these results have remained either incomplete or unsuccessful. [The concept of
synthetic lethality is discussed in more detail in a subsequent introductory sub-section
below.]
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Intracellular Localization and Potential Biological Role of Ecm14
In a cellular analysis of protein localization in S. cerevisiae, Huh et al. (2003)
identified Ecm14 to be localized within the yeast vacuole, an important organelle involved
in yeast cell wall architecture and remodeling. By inserting the coding sequence for green
fluorescent protein (GFP) from Aequorea victoria (a bioluminescent jellyfish species) inframe immediately preceding the endogenous stop codon for each yeast ORF (open reading
frame), Huh et al. (2003) were able to provide a comprehensive map of in vivo protein
localization in the yeast S. cerevisiae.
In yeast, the vacuole localizes the key enzymatic players of the macroautophagy
pathway. [The yeast vacuole is functionally analogous to the lysosomes found in higher
eukaryotes.] This ubiquitous homeostatic process facilitates the degradation of damaged
organelles and misfolded proteins in response to a variety of metabolic signals and stressors
(Levine et al., 2011). Furthermore, the vacuole is responsible for the degradation of several
enzymes specifically implicated in cell wall biology (Wiederhold et al., 2009). For
example, one recognized pathway for regulating chitin synthase II (Chs2) is via vacuolar
degradation by the vacuolar aspartyl protease A (Pep4) (Chuang & Schekman, 1996). In
response to some yet to be characterized signal, Chs2 is trafficked via endocytosis into the
yeast vacuole by Sla2 for eventual degradation (Lesage & Bussey, 2006).
Like Ecm14, Proteinase C (Prc1, a serine carboxypeptidase Y) and Autophagy-42
(Atg42, a functional homologue of Prc1) are both localized in the yeast vacuole (Huh et
al., 2003). Parzych et al. (2018) demonstrated that deficiencies in both Atg42 and Prc1
result in several defects in the yeast macroautophagy pathway. Following hydrolysis, the
resultant components are released into the cytosol via newly synthesized permease-like
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proteins (Yang et al., 2006). However, the present evidence suggests that yeast with
mutations in both Atg42 and Prc1 have significant deficiencies in the breakdown of
autophagic-bodies, the activation of vacuolar zymogens, and the synthesis of various
autophagy-dependent proteins (Parzych et al., 2018).
Another vacuolar carboxypeptidase in S. cerevisiae is Carboxypeptidase S (Cps1).
Bordallo and Suarez-Rendueles (1993) demonstrated that yeast pre-cultured in a nitrogen
and glucose-rich growth medium show a dramatic increase in CPS1 expression when
subsequently deprived of nitrogen. Like Atg42 and Prc1, the upregulation of Cps1 activity
during periods of nutrient deprivation likely suggests a crucial mechanism of homeostasis.
In the case of Cps1, this mechanism seems to invoke the recycling of certain peptides (as
catalyzed by Cps1) for use as an alternative source of metabolic nitrogen during periods of
nitrogen depravation (Bordallo & Suarez-Rendueles, 1993).
Although Ecm14 seems to lack traditional carboxypeptidase-like activity, its
homology with active peptidases, its implication in resistance to calcofluor white, and its
localization in the yeast vacuole seem to suggest a possible uncharacterized role in cell
wall architecture and remodeling.
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Synthetic Lethality and the Synthetic Lethal Screen
The phenomenon of synthetic lethality occurs when two or more genetic
perturbations together result in cellular death (Dobzhansky, 1946; Nijman, 2011).
Biochemical pathways typically involve multiple key genetic components and it is thought
that many of these key gene players can provide some redundancy in the event that other
genes experience deleterious mutations (see Figure 9). Although enzymes are generally
characterized based on a primary native reaction, enzymes (and potentially their inactive
homologues) can also participate in numerous secondary side reactions and processes. This
theory of “genetic robustness” suggests that organisms are quite resistant to major
phenotypic changes despite inherent genetic variability, environmental changes and
random mutation events.

Figure 9. The phenomenon of synthetic lethality.
Biochemical pathways typically involve multiple key gene components and many
of these key gene players provide redundancy if other genes experience deleterious
mutations (*). The synthetic lethal screen identifies novel mutants (gene-y) whose
survival depends on a gene of interest (GENE-X).
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One method for exploring the function of non-essential genes is the synthetic lethal
screen. This screen incorporates a convenient color-colony reporting assay to quickly
visualize dependence on a plasmid carrying a gene of interest required for cell survival
(Barbour et al., 2000; Koshland et al., 1985). The color-colony reporting assay exploits the
de novo adenine biosynthesis pathway involving at least seven major genetic players
(named ADE1-7). In short, cells carrying an ade2 mutation accumulate the intermediate
P-ribosylaminoimidazole, which is oxidized to a red pigment. However, the ade3 mutation
is epistatic to ade2 and, thus, blocks the pathway at a point prior to pigment formation.
Thus, both wild-type and ade3/ade2 double mutant yeasts are white, and ade2 single
mutant yeast are red (see Figure 10). However, double ade3/ade2 mutant yeasts
transformed with a plasmid carrying a functional ADE3 gene are red (see Figure 10).
Transformants that only weakly retain the plasmid will produce red and white sectored
colonies to varying degrees.

Figure 10. The genetic basis for the red-white color-colony assay in yeast.
(1) Wild-type yeast are white. (2) Yeast that contain a single ade2 mutation
accumulate a red pigment (oxidized P-ribosylaminoimidazole). (3) Yeast that
contain both ade3 and ade2 mutations result in white colonies. (4) These double
mutants that are transformed with a plasmid containing a functional ADE3 gene
[pADE3] are red.
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A synthetic lethal screen begins by first deleting a gene of interest in a yeast strain
that is already deficient in the adenine biosynthesis pathway (ade3/ade2 mutants that
produce white colonies). [The yeast gene deletion strategy is discussed in more detail in a
subsequent methods sub-section.] Additionally, this host yeast strain must also contain an
auxotrophic marker for selecting transformants (e.g. ura3Δ is commonly used) and
complementary auxotrophic or drug resistance markers for selecting diploids from mating
reactions (Sadowski et al., 2008). In URA3-based selection, the plasmid DNA has a wildtype copy of the yeast URA3 gene, as well as the URA3 promoter; however, the host yeast
strain lacks the URA3 allele. Thus, yeast cells transformed with the plasmid have a
functional copy of the URA3 gene, which allows them to grow on media lacking uracil.
Conversely, URA3-based selection also enables negative selection against plasmids
containing URA3 when grown on media containing 5-fluoroorotic acid (5-FOA). When 5FOA is added to the growth media, the active URA3 gene product (orotidine 5'-phosphate
decarboxylase) converts 5-FOA into the toxic compound 5-fluorouracil (5-FU). These
URA3-containing plasmids are effectively destabilized and rapidly lost when grown on
media containing 5-FOA. The S. Cerevisiae W303 strain (MATa/MATα {leu2-3,112
trp1-1 can1-100 ura3-1 ade2-1 his3-11,15}) is commonly used as the parent strain when
performing synthetic lethal assays (Cherry et al., 2012).
After creating a suitable knockout W303-derived yeast strain, a wild-type copy of
the gene of interest is cloned into a plasmid specifically designed for yeast synthetic lethal
screens (Barbour et al., 2000). As a shuttle vector, this pSLS1 plasmid contains sequences
for proliferation and selection in both bacteria and yeast. As a vector for synthetic lethal
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screens, this pSLS1 plasmid also contains a functional ADE3 gene and a yeast centromere
(CEN4) under the influence of a galactose promotor (pGAL1) (see Table 2 and Figure 11).

Figure 11. The pSLS1 plasmid for yeast synthetic lethal screens.
The pSLS1 plasmid contains the bacterial origin of replication sequence (ORI), the
ampicillin resistance gene (AmpR) for selection in bacteria, the CEN/ARS
sequence for replication in yeast, the URA3 gene for selection in yeast, and the
ADE3 gene for color-colony reporting.
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When grown on media containing galactose, the galactose promotor erroneously
induces transcription through the traditionally un-transcribed CEN4 sequence (see above
Figure 11). The CEN4 sequence normally causes these yeast centromere plasmids (YCp)
to behave like low-copy, “mini-chromosomes” during cell division (Clarke & Carbon,
1980). However, erroneous transcription through the centromere sequence causes these
YCp plasmids to instead behave like highly unstable yeast replicating plasmids (YRp).
Therefore, providing galactose as a carbon source functions as a molecular switch causing
the pSLS1 centromere plasmid to instead behave more like a replicating plasmid (Barbour
et al., 2000). This ability to regulate plasmid stability in vivo is an essential requirement for
effective synthetic lethal screens and has been shown to significantly reduce the number of
false positives that must be subsequently screened and interrogated (Barbour et al., 2000).
The synthetic lethal screen functions on the basis that dependence of the gene of
interest for survival will cause yeast to retain the plasmid and, thus, produce non-sectored
red colonies when grown on galactose-containing media (Barbour et al., 2000). However,
yeast that are not dependent on the plasmid for survival will rapidly lose the plasmid when
grown on galactose-containing media and produce red and white sectored colonies, or even
solid white colonies, depending on the rate of plasmid retention. It is thought these sectored
colonies are caused by the natural differential retention of the plasmid under various nonessential contexts and should ideally be avoided when selecting candidate yeast colonies
for further investigation.
Spontaneous mutations occur at a rate far too low to be practically useful for most
genetic screens. However, carefully prescribed treatment with either ethyl methansulfonate
(EMS) or ultraviolet (UV) light can significantly increase the rate of mutations per gene
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without the excessive killing of cells (Winston, 2008). As a potent base-altering agent,
EMS is known to add an ethyl group to guanine, forming O6-ethylguanine (see Figure 12).
This alkylated guanine can no longer form the typical three hydrogen bonds with cytosine
and, thus, can erroneously be mispaired with thymine by DNA polymerase during DNA
replication, causing G/C→A/T transitions (Brookes & Lawley, 1961). Since stop codons
are rich in ATs (i.e. TAA, TGA, and TAG), EMS-based mutagenesis is effective for
generating nonsense mutations. Because truncated gene products are generally not useful
or even partially functional, these types of nonsense mutations are preferred when
conducting synthetic lethal screens.

Figure 12. EMS-induced alkylation of guanine to form O6-ethylguanine.
Guanine can form three hydrogen bonds (*). However, O6-ethylguanine can only
form two hydrogen bonds (*) and, thus, can erroneously mispair with thymine
during DNA replication.
The synthetic lethal screen can be described by three primary steps. First, a W303derived knockout yeast strain is transformed with a pSLS1-based plasmid containing a
wild-type copy of the gene of interest (GENE-X). Next, random mutagenesis introduces
random point mutations throughout the yeast genome. Finally, these mutagenized yeasts
are cultured and screened on galactose-rich media to induce plasmid destabilization and
the accumulation of the red pigment (see Figure 13).
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Figure 13. The synthetic lethal assay is used to identify novel mutant yeast strains
whose survival is dependent on a gene of interest.
(1) A wild-type gene of interest (GENE-X) is first moved from the yeast genome
into the pSLS1 vector (pSLS1-GENE-X). (2) Random genomic point mutations are
introduced throughout the yeast genome using ethyl methansulfonate (EMS) or
ultraviolet (UV) light. (3) Colonies that depend on the gene of interest for survival
can be visualized by screening for non-sectored red colonies.
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CHAPTER 2
GENERAL MATERIALS AND METHODS
Yeast Cell Culture and Media
YEPD media (Yeast Extract 10 g/l, Peptone 20 g/l, Dextrose 20 g/l) was used for
the routine maintenance and propagation of yeast. When necessary, this routine YEPD
growth media was also supplemented with 8 ml/l of 0.5% (w/v) adenine (YEPD+Ade) for
yeast strains deficient in adenine biosynthesis. Filter-sterilized Geneticin® (G418 sulfate,
500 μg/ml) was used to select for yeast containing the KanMX allele. Filter-sterilized
nourseothricin sulfate (NTC, 100 μg/ml) was used to select for yeast containing the NatMX
allele. Both G418 and NTC were added to warm media (≈55°C). When preparing Petri
dishes, agar was added at 20 g/l.
SC-Ura media (Synthetic Complete minus Uracil) was used to positively select for
yeast transformed with a plasmid containing the URA3 allele. This SC-Ura media
contained 1% (w/v) succinic acid, 0.6% (w/v) sodium hydroxide, 0.67% (w/v) yeast
nitrogenous base, and 1% (w/v) casamino acids. A 0.5% (w/v) autoclaved adenine stock
was added at 8 ml/l. A 1% (w/v) filter-sterilized tryptophan stock was added at 2 ml/l (small
drips of 3 M sodium hydroxide were added, as necessary, to increase tryptophan solubility
in water). A 20% (w/v) dextrose stock was autoclaved separately in order to prevent
caramelization and undesirable Maillard side reactions with amino acids in solution. This
20% (w/v) dextrose stock was added at 100 ml/l. Adenine, tryptophan and dextrose were
added to warm media (≈55°C). When preparing Petri dishes, agar was added at 20 g/l.
SC+5FOA media (Synthetic Complete plus 5-Fluoroorotic Acid) was used to
negatively select for yeast transformed with a plasmid containing the URA3 allele. This
40

SC+5FOA media was made as above, with the addition of a 0.2% (w/v) autoclaved uracil
stock that was added at 5 ml/l. Finally, 100X 5-FOA from Zymo Research (100 mg/ml in
DMSO) was added to warm media at 10 ml/l.
YPGal media (Yeast Extract 10 g/l, Peptone 20 g/l, Galactose 20 g/l) was used for
the destabilization of yeast centromere plasmids (YCp) under the influence of the galactose
promoter (GAL1). A 20% (w/v) galactose stock was either autoclaved separately or filtersterilized in order to prevent caramelization and undesirable Maillard side reactions with
amino acids in solution. Galactose was added to warm media (≈55°C). When preparing
Petri dishes, agar was added at 20 g/l.
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Bacterial Cell Culture and Media
Luria broth (sodium chloride 10 g/l, tryptone 10 g/l, and yeast extract 5 g/l) was
used for the routine maintenance and propagation of DH5α Escherichia coli. Filtersterilized 1000X ampicillin stock (100 mg/ml) was added to warm media (≈55°C) at 1 ml/l
(or μl/ml). When preparing plates, agar was added at 15 g/l. For blue-white screening
plates, filter-sterilized 100X IPTG (100 mM) and filter-sterilized 100X X-Gal (20 mg/ml)
were added to warm media (≈55°C) at 10 ml/l (or μl/ml).
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Gel Extraction and Cleanup of Large DNA Fragments
The Qiagen QIAquick™ Gel Extraction Kit was used to cleanup DNA fragments
from agarose gels following various enzymatic reactions. Although the QIAquick Gel
Extraction Kit is only officially rated for up to 10 μg DNA (70-bp to 10-kb), several
modifications to the included quick-start protocol allowed for the dependable extraction of
larger DNA fragments (>10-kb). Bands of interest were sparingly visualized using UV
transillumination, excised using clean scalpel blades (either fresh or cleaned using RNase
AWAY™ as a DNA decontamination reagent), and transferred into tared 2-ml
microcentrifuge tubes. Gel slices were excised and trimmed to <400 mg per extraction
tube. Gel slices were incubated at 50°C for 10 minutes in three gel volumes of Buffer QG.
Each incubating gel slice was vortexed every 2 minutes in order to thoroughly dissolve
each gel slice. One gel volume of isopropanol was added to each tube and thoroughly
vortexed. Each sample was applied to the center of a fresh QIAquick spin column,
centrifuged for 90 seconds at 21,130g, and the flow-through discarded (this was repeated
as needed for sample volumes >750 μl). An additional 500 μl of fresh Buffer QG was
washed through each column in order to remove all traces of agarose. 750 μl of Buffer PE
was carefully added to the center of each spin column and allowed to incubate at room
temperature for >5 minutes. The Buffer PE wash was centrifuged for 90 seconds at 21,130g
and the flow-through discarded. Each spin column was subsequently rotated 180 degrees
and centrifuged for an additional 90 seconds at 21,130g to remove any residual Buffer PE.
Residual Buffer PE (containing ethanol) can interfere with downstream applications. DNA
was eluted by carefully applying 50 μl of warm Buffer EB (55-65°C) to the center of each
spin column and allowing each to incubate at room temperature for >5 minutes. Each spin
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column was placed into a clean 1.5-ml microcentrifuge tube and centrifuged for 90 seconds
at 21,130g to elute the DNA. Multiple spin columns were used for samples exceeding 400
mg. Serial elutions were used to successively collect and concentrate DNA from multiple
columns. Final preparations were stored at -20°C.
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Isolation of Yeast Genomic DNA for PCR-based Applications
Yeast genomic DNA (gDNA) was isolated using an inexpensive and quick
approach based on a technique by Looke et al. (2011) from the Institute of Molecular and
Cell Biology, University of Tartu, Estonia. Either a single colony or 200 μl of mid-log
phase liquid culture (1-5x107 cells/ml, OD600 = 0.4-1.7) was resuspended in 100 μl of fresh
200 mM lithium acetate, 1% SDS solution and incubated for 10 minutes at 70°C. 300 μl of
100% ethanol was added and samples were thoroughly vortexed prior to 3 minutes of
centrifugation at 21,130g. Samples were carefully decanted and the supernatant discarded.
Pellets were subsequently re-washed with 500 μl of 70% ethanol and allowed to air-dry for
>10 minutes prior to being resuspended in 100 μl of Qiagen® Buffer EB (10 mM Tris-Cl,
pH 8.5). Samples were briefly centrifuged for 15 seconds to collect cell debris and 1 μl of
supernatant was used for PCR template DNA.
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Isolation of Plasmid DNA From Bacterial Cells Using the NID Method
Plasmid DNA was routinely isolated using the “one-step, one-tube” non-ionic
detergent (NID) method demonstrated by Lezin et al. (2011). The NID extraction buffer
(5% sucrose, 20-50 mM EDTA, 50 mM Tris pH 8, 0.75 M NH4Cl, and 0.5% Triton X-100)
was stored without enzyme at 4°C. A separate 100X enzyme stock (10 mg/ml lysozyme,
2.5 mg/ml RNase A, 50 mM Tris pH 8, and 50% glycerol) was stored at -20°C and added
as necessary. For small 50-μl minipreps, LB/Amp cultures (2-4 ml) were inoculated with
fresh monoclonal bacterial colonies-of-interest and cultured overnight for 16-18 hours at
37°C with shaking at 250 RPM. These overnight cultures were split into 2-ml
microcentrifuge tubes and pelleted at 5,000g for 1 minute. Each decanted pellet was
thoroughly resuspended in 150 μl of extraction buffer (with enzymes) and incubated at
65°C for 5-7 minutes. For overnight cultures >2 ml, identical pellets were serially
resuspended and collected in the same 150 μl of extraction buffer (with enzymes) prior to
incubation for increased plasmid concentrations. Suspensions were centrifuged at 21,130g
for 10 minutes and each cellular pellet was carefully removed using a sterile toothpick.
Plasmid DNA was precipitated and pelleted by adding 120 μl of isopropanol, followed by
thorough mixing and centrifugation at 5,000g for 10 minutes. Finally, 500 μl of 70%
ethanol was added, followed by centrifugation at 21,130g for 10 minutes. After removing
the ethanol supernatant, each pellet was allowed to thoroughly dry for 10-15 minutes prior
to being dissolved in 50 μl of Qiagen Buffer EB.
Large 200-μl maxipreps were prepared by first inoculating 1-ml LB/Amp seed
cultures with fresh monoclonal bacterial colonies-of-interest and incubating for 8 hours at
37°C with shaking at 250 RPM. These 8-hr seed cultures were then used to inoculate larger
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100-ml LB/Amp cultures that were subsequently incubated overnight at 37°C with shaking
at 250 RPM. Each 100-ml overnight culture was divided between three sterile 50-ml
centrifuge tubes and pelleted at 5,000g for 5 minutes in a refrigerated centrifuge (4°C).
Identical pellets were serially resuspended using 10 ml of prepared NID extraction buffer
and consolidated into one 50-ml centrifuge tube. Suspensions were incubated in a water
bath at 65°C for 8 minutes and centrifuged at 13,000g for 30 minutes in a refrigerated
centrifuge (4°C). Plasmid DNA was precipitated and pelleted by adding 1 ml of
isopropanol, followed by thorough mixing and centrifugation at 13,000g for 15 minutes in
a refrigerated centrifuge (4°C). Each plasmid pellet was thoroughly resuspended in 1.5 ml
of 70% ethanol, transferred to a clean 1.5-ml microcentrifuge tube, and centrifuged at
21,130g for 5 minutes at room temperature. After removing the ethanol supernatant, each
pellet was allowed to thoroughly dry for 10-15 minutes prior to being dissolved in 500 μl
of Qiagen Buffer EB.
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DNA Quantification using ImageJ
DNA agarose gels were imaged using the AlphaImager HP™ gel imaging system
and analyzed using NIH ImageJ (Rueden et al., 2017). These images were intentionally
captured using a very low auto exposure profile to ensure more accurate final band
quantification. Each gel image was opened in ImageJ and a bounding box was drawn
around the entire DNA ladder using the Rectangle Tool. This first lane was marked by
either pressing Control + 1 or via the Analyze > Gels > “Select First Lane” menu option.
The box was then duplicated onto each lane of interest by dragging and marking these
subsequent lanes by either pressing Control + 2 or via the Analyze > Gels > “Select Next
Lane” menu option. The “Invert peaks” option was unselected (Analyze > Gels > “Gel
Analyzer Options…”). Finally, lanes were plotted by either pressing Control + 3 or via the
Analyze > Gels > “Plot Lanes” menu option (see Figure 14).
Each peak of interest was area-bound by drawing a line using the straight-line tool
underneath each peak between the predominate points of inflections above baseline. The
magic wand tool was then used to select each enclosed, area-bound peak and each peak
was labeled using the Analyze > Gels > “Label Peaks” menu option. Usually the bright
3.0-kb TriDye band was used as a reference standard for all DNA quantification
experiments. When using a 5 μl load of TriDye, the 3.0-kb band has as reference mass
(Rmass) of 62.5 ng. The masses of each band of interest (Bmass) were calculated by simply
relating the known peak area (Rarea) and mass (Rmass) of the 3.0-kb TriDye band to the peak
area (Barea) of bands of interest in subsequent lanes (see Figure 14):

𝐵𝑚𝑎𝑠𝑠 =

𝐵𝑎𝑟𝑒𝑎 𝑅𝑚𝑎𝑠𝑠
𝑅𝑎𝑟𝑒𝑎
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The mass of each band of interest was then converted to concentration (ng/μl) by
dividing by the volume of DNA that was loaded into the agarose gel. This volume of DNA
was usually the amount used in a preceding diagnostic restriction digest (e.g. 5 μl).

Figure 14. DNA quantification using ImageJ and Microsoft Excel.
(A) The DNA ladder lane and any additional lane-of-interest is selected in ImageJ
using the rectangle tool. (B) The peak intensities of each lane are then automatically
plotted, and each peak is area-bound using the straight-line tool. (C) Each areabound peak is then selected using the magic-wand tool and labeled. (D) Finally.
these calculated peak intensities are converted to DNA concentrations for each
band-of-interest (BOI).
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CHAPTER 3
PLASMID CONSTRUCTION METHODS AND RESULTS
High-Fidelity PCR Amplification of Wild-type ECM14
Primer sequences for amplifying the Saccharomyces cerevisiae ECM14
(YHR132C) open reading frame (ORF) were obtained from the Saccharomyces Genome
Deletion Project (Baudin et al., 1993; Wach et al., 1994). These forward (_A) and reverse
(_D) ORF primers are designed to also include several hundred bases of flanking sequence
around the targeted gene to ensure adequate coverage of both endogenous promotor and
terminator sequences. As such, amplicons produced using these forward and reverse
primers (e.g. ECM14_A and ECM14_D) are referred to as “expression cassettes.” In
addition to the standard ECM14_A and ECM14_D primers, slightly modified primers were
designed to include a 5’ BamHI restriction site (ECM14_A-BamHI and ECM14_DBamHI) for future ligation into various plasmid vectors. These BamHI primers also
included a 4-bp TATA sitting sequence preceding the GGATCC BamHI recognition site
on the 5’ end to facilitate optimal enzyme binding and interaction. All primers were ordered
from Thermo Fisher Scientific® (see Table 1) and reconstituted with Buffer EB (10 mM
Tris-Cl, pH 8.5) to 100 μM. These reconstituted primers were further diluted to a final
working concentration of 10 μM before being used in PCR or Sanger sequencing reactions.
Genomic DNA was extracted from ECM14 wild-type Y1239 yeast cells cultured
on standard YEPD media. The high-fidelity Platinum SuperFi® DNA Polymerase from
Invitrogen® was used to amplify the ECM14 ORF. A PCR master mix was prepared for
n+1 reactions (n=4) by combining 127.5 μl of sterile Milli-Q® water, 50 μl of 5X SuperFi
buffer, 20 μl of 2mM dNTP mix, and 2.5 μl of SuperFi DNA Polymerase (2 U/μl). Either
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5 μl or 1 μl of Y1239 gDNA was used as template DNA with both the standard ECM14
and modified ECM14-BamHI primers to a final volume of 50 μl per reaction. Forward and
reverse primers were added to a final concentration of 0.5 μM. Each reaction tube was
capped and carefully mixed before placing into a Bio-Rad® T100 Thermal Cycler. The
following thermal profile was performed: initial denaturation at 98°C for 30 seconds,
followed by 35 cycles of denaturation at 98°C for 10 seconds, annealing at 63.6°C for 10
seconds, and extension at 72°C for 60 seconds. The profile was completed with a final
extension at 72°C for 5 minutes. Each PCR reaction was combined with 10 μl of New
England Biolabs’® Gel Loading Dye, Purple (6X) and ran in a 0.8% agarose gel (0.5 μg/ml
EtBr) for visualization and gel extraction/cleanup (see Figure 15).
The pSLS1 vector contains only three unique restriction sites (BamHI, SalI, and
SmaI) for subcloning applications (see above Figure 11). Thus, it was required to utilize
custom PCR primers in order to introduce novel restriction sites (preferably those with
sticky ends) flanking the traditional ECM14 amplicon. The original ECM14_A and
ECM14_D primers from the Saccharomyces Genome Deletion Project were used as a
control to demonstrate amplification of wild-type ECM14 (1.9 kb) from Y1239 gDNA.

Figure 15. High-fidelity PCR amplification of wild-type ECM14.
The original ECM14_A and ECM14_D primers were used to demonstrate
amplification of wild-type ECM14 (1.9 kb) from Y1239 gDNA. Custom
ECM14_A and ECM14_D primers were designed to harbor terminal BamH1
restriction sites to facilitate future ligation into various plasmid vectors. Either 1 μl
or 5 μl of template Y1239 gDNA was used in each PCR reaction. All four reactions
were successful in amplifying ECM14.
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Cloning of Wild-type ECM14 into pBluescript
The ECM14 PCR product harboring terminal BamHI restriction sites and the target
pBluescript II SK(+) plasmid vector were both digested with the New England Biolabs’
BamHI-HF restriction enzyme. [Although there are four commercially available variants
of the pBluescript II vector, these differences were not of interest in this study. Any one of
these pBluescript variants can be used as a routine cloning plasmid.] For the ECM14BamHI PCR product, 50 μl of gel-purified PCR product was combined with 6 μl of
CutSmart Buffer, 2 μl of sterile Milli-Q water, and 2 μl of BamHI-HF enzyme. For
pBluescript II SK(+), 2 μl of pBluescript plasmid (1 μg/μl) was combined with 15 μl of
sterile Milli-Q water, 2 μl of CutSmart Buffer, and 1 μl of BamHI-HF enzyme. Both
digestion reactions were thoroughly incubated at 37°C for >1 hour and were cleaned up
immediately using the QIAquick gel extraction kit without actually running each digest in
an agarose gel (3 volumes of Buffer QG and 1 volume of isopropanol were simply added
prior to applying each digest to a fresh spin column). The pBluescript-BamHI digest was
additionally treated with 1 μl of New England Biolabs’ Calf Intestinal Alkaline
Phosphatase (CIAP) to remove 5’ terminal phosphate groups and, thus, prevent vector recircularization during subsequent ligation reactions. This CIAP-treated pBluescript-BamHI
digest was also cleaned up immediately using the QIAquick kit. Each cleaned-up digest
was quantified in a 0.8% agarose gel (0.5 μg/ml EtBr) with 5 μl TriDye Ladder as a
reference standard.
The ECM14-BamHI insert was ligated into the pBluescript-BamHI-CIAP vector
using T4 DNA ligase with a standard vector-to-insert ratio of 1:3. The ligation reaction
contained 6 μl of pBluescript-BamHI-CIAP (0.042 pmol), 4 μl of ECM14-BamHI (0.126
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pmol), 7 μl of sterile Milli-Q water, 2 μl of T4 DNA ligase buffer, and 1 μl of T4 DNA
ligase. The ligation reaction was incubated at 24°C for 1 hour. Three 50-μl aliquots of
Invitrogen Subcloning Efficiency™ DH5α Competent Cells were slowly thawed on wet
ice and mixed with either 5 μl of sterile Milli-Q water (negative control), 5 μl pBluescriptECM14 ligation mixture, or 1 μl pBluescript (positive control). Each transformation
mixture was incubated on wet ice for 30 minutes, heat shocked at 42°C for 45 seconds, and
returned to wet ice for 5 minutes. Each reaction was incubated for 60 minutes at 37°C in
200 μl of fresh LB without ampicillin to allow for adequate expression of the ampicillin
resistance gene prior to plating. These outgrowth cultures were subsequently plated on dry
IPTG/X-Gal LB agar plates with ampicillin (starting with the negative control first),
incubated at 37°C overnight for >20 hours, and screened for white colonies.
Four putative pBluescript-ECM14 colonies (white) were cultured overnight,
miniprepped using the NID method, and digested with BamHI-HF enzyme at 37°C for 60
minutes. Each of these diagnostic restriction digests included 5 μl of plasmid DNA, 12 μl
of sterile Milli-Q water, 2 μl of CutSmart Buffer, and 1 μl of BamHI-HF enzyme. Each
digest was electrophoresed in a 0.8% agarose gel (0.5 μg/ml EtBr) at 100V until sufficient
band separation (see Figure 16). The combined peak area of both the pBluescript band and
the ECM14 band were used to calculate the concentration of each plasmid preparation.
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Figure 16. Cloning of Wild-type ECM14 into pBluescript.
The wild-type ECM14 PCR product harboring terminal BamHI sites and the
pBluescript II SK(+) vector were first digested with BamH1. The pBluescript
vector was then treated with an alkaline phosphatase (CIAP) prior to ligation by T4
DNA ligase. Four putative pBluescript-ECM14 preparations and empty pBluescript
II (3.0 kb) were digested with BamHI to confirm the presence or absence of the
ECM14 gene insert (1.9 kb).
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Confirmation of ECM14 Sequence Accuracy
Sanger sequencing was performed by GenScript (Piscataway, N.J.) The four
putative pBluescript-ECM14 plasmids were sequenced using the ECM14_A, ECM14_D,
and ECM14_Internal primers (see Table 1) to ensure adequate sequencing coverage of the
ECM14 gene insert. Three sequencing samples for each plasmid were prepared by
premixing 10 μl of plasmid DNA (>50 ng/μl), 2.5 μl (50 pmol) of primer (either
ECM14_A, ECM14_D, or ECM14_Internal), and 2.5 μl of sterile Milli-Q water. Samples
were shipped overnight in 1.5-ml microcentrifuge tubes sealed with Parafilm.
Sequencing results were first processed by visually inspecting the chromatograms
using either Chromas or UGENE for base call quality and subsequently truncating any poor
terminal sequence as necessary (Okonechnikov et al., 2012). Each sequence was then
aligned with the wild-type ECM14 reference sequence using NCBI Nucleotide BLAST
(BLASTn) and inspected for any sequence gaps and erroneous base identities. Any
discrepancies were further considered by manually re-inspecting the chromatograms and,
when possible, comparing regions of overlapping sequence coverage for any additional
clues for determining consensus. Finally, the three contiguous sequences were assembled
using the CAP3 sequence assembly program and saved in FASTA format.
The ECM14 insert sequence produced by this study was merged with the
pBluescript II SK(+) sequence in SnapGene to produce new recombinant pBluescriptECM14 maps for both orientations (see Figure 17).
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Figure 17. Diagrams of the ECM14-BamHI PCR product, the pBluescript II SK(+)
vector, and both orientations of the pBluescript-ECM14 recombinant plasmid.
(A) The ECM14 PCR product harboring terminal BamHI restriction sites. Relevant
primer sites for amplification and sequencing are annotated. (B) The pBluescript II
SK(+) plasmid contains a multiple cloning site (MCS) and blue-white screening
capability (LacZα). (C, D) Either ECM14 insert orientation is possible in the
recombinant pBluescript-ECM14 plasmid due to only one restriction enzyme being
used for cloning. Only plasmid features relevant to this study are annotated (*).
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Subcloning of ECM14 from pBluescript-ECM14 into pSLS1
The wild-type ECM14 gene insert was subcloned from the pBluescript-ECM14
(4,838-bp) parent plasmid into the pSLS1 (10.8-kb) destination plasmid. At least 2 μg of
both pBluescript-ECM14 and pSLS1 were thoroughly digested with BamHI to ensure
adequate recovery yields for future downstream applications. For pBluescript-ECM14, 12
μl of pBluescript-ECM14 plasmid (170 ng/μl) was combined with 32 μl of sterile Milli-Q
water, 5 μl of CutSmart Buffer, and 1 μl of BamHI-HF enzyme. For pSLS1, 7 μl of pSLS1
plasmid (300 ng/μl) was combined with 37 μl of sterile Milli-Q water, 5 μl of CutSmart
Buffer, and 1 μl of BamHI-HF enzyme. Both digestion reactions were allowed to incubate
for >5 hours at 37°C. The pSLS1-BamHI digest was additionally treated with 2 μl of Calf
Intestinal Alkaline Phosphatase (CIAP) to remove 5’ terminal phosphate groups and, thus,
prevent vector re-circularization during subsequent ligation reactions. Both digests were
electrophoresed in a 0.8% agarose gel (0.5 μg/ml EtBr) for 60 minutes in order allow for
sufficient separation of the pBluescript (2,961-bp) and ECM14 (1,883-bp) bands. The
pSLS1 and ECM14 bands were both gel extracted using the modified protocol for large
DNA fragments, ran in an additional 0.8% agarose gel (0.5 μg/ml EtBr), and quantified
using ImageJ.
The pSLS1-ECM14 ligation reaction was performed overnight at 16°C with a 1:3
vector-to-insert ratio. This ligation reaction contained 5 μl of ECM14-BamHI (20 ng/μl,
0.081 pmol), 2 μl of pSLS1-BamHI-CIAP (94 ng/μl, 0.026 pmol), 10 μl of sterile Milli-Q
water, 2 μl of T4 DNA Ligase Buffer, and 1 μl of T4 DNA Ligase. An additional ligation
reaction lacking ECM14-BamHI was also performed as a test for CIAP treatment efficacy.
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Additionally, the pSLS1-ECM14 ligation reaction was further diluted 5X as recommended
by the Invitrogen Max Efficiency™ DH5α transformation protocol.
A fresh 200-μl aliquot of Invitrogen Max Efficiency DH5α was slowly thawed on
wet ice, split into four 50-μl aliquots, and gently mixed with either 5 μl of the pSLS1ECM14 ligation reaction, 5 μl of the 5X dilution, 5 μl of the CIAP ligation control, or 1 μl
of pUC19 control plasmid. Each transformation mixture was incubated on wet ice for 30
minutes, heat shocked at 42°C for 45 seconds, and returned to wet ice for 2 minutes. Each
reaction was incubated for 60 minutes at 37°C in 450 μl of fresh SOC without ampicillin
to allow for adequate expression of the ampicillin resistance gene prior to plating. These
outgrowth cultures were subsequently plated on dry LB agar plates (250 μl/plate) with
ampicillin and incubated at 37°C overnight for >20 hours. The pUC19 control
transformation was plated on dry IPTG/X-Gal LB agar plates with ampicillin.
Twelve putative pSLS1-ECM14 colonies were cultured overnight and miniprepped
using the NID method. Nine putative pSLS1-ECM14 plasmids (1, 3, 4, 5, 6, 7, 8, 11 and
12) were randomly selected and digested with BamHI-HF at 37°C for 60 minutes. Each of
these diagnostic digests included 5 μl of plasmid DNA, 12 μl of sterile Milli-Q water, 2 μl
of CutSmart Buffer, and 1 μl of BamHI-HF enzyme. Each digest was electrophoresed in a
0.8% agarose gel (0.5 μg/ml EtBr) and imaged using the AlphaImager HP gel imaging
system (see Figure 18). Only those digests that clearly liberated both a pSLS1 band (10.8kb) and an ECM14 band (1,883-bp) were considered for further interrogation (1, 3, 5, and
7). The remaining digests (4, 6, 8, 11, and 12) contained a pBluescript band (2,961-bp)
instead of a pSLS1 band and were discarded.
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Figure 18. Cloning of wild-type ECM14 from pBluescript-ECM14 into pSLS1.
The sequenced-verified ECM14 gene insert was subcloned from the pBluescriptECM14 (4.8 kb) parent plasmid into the pSLS1 (10.8 kb) destination vector. Nine
putative pSLS1-ECM14 preparations were screened using a BamHI diagnostic
digest. Only those digests that clearly liberated both a pSLS1 band (10.8 kb) and
an ECM14 band (1.9 kb) were considered for further interrogation (*).
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Determination of ECM14 Insert Orientation in pSLS1-ECM14
A sequential diagnostic restriction digest with SmaI and EcoRI was performed in
order to determine the orientation of the ECM14 gene insert in pSLS1-ECM14. Because
only a single restriction enzyme was used during the original subcloning procedure, either
insert orientation was equally probable. Although the ECM14 gene insert includes both
endogenous promotor and terminator sequences (and, thus, should be transcribable in either
orientation), it was still desirable to document the orientation for future reference.
SmaI and EcoRI were intentionally chosen for this experiment based on two
underlying assumptions: 1) SmaI cuts only within the parent vector and 2) EcoRI cuts
asymmetrically within the gene insert. [These two basic assumptions can be applied to
similar experiments.] The restriction sites within the ECM14 insert sequence produced by
this study were mapped using EMBOSS Restrict (Hancock & Bishop, 2014) and SnapGene
(from GSL Biotech; available at snapgene.com). It was noted that EcoRI cuts the ECM14
insert sequence 378 bases from one end.
Due to incompatible incubation temperatures, the SmaI digest was performed first
at the lower temperature of 25°C (5 μl of plasmid DNA, 12 μl of sterile Milli-Q water, 2
μl of CutSmart Buffer, and 1 μl of SmaI enzyme). The EcoRI digest was performed next
at 37°C (5 μl of plasmid DNA, 12 μl of sterile Milli-Q water, 2 μl of CutSmart Buffer, and
1 μl of EcoRI-HF enzyme). Each diagnostic digest was thoroughly incubated for >1 hour.
Each diagnostic digest was combined with 4 μl of New England Biolabs’ Gel Loading Dye,
Purple (6X), ran in a 0.8% agarose gel (0.5 μg/ml EtBr) at 100V until sufficient band
separation, and imaged using the AlphaImager HP gel imaging system (see Figure 19).
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Figure 19. Determination of ECM14 insert orientation in pSLS1-ECM14.
A sequential diagnostic restriction digest with SmaI and EcoRI was performed in
order to determine the orientation of the ECM14 gene insert in pSLS1-ECM14.
The complete restriction map for the pSLS1 plasmid was recreated in silico using
the original plasmid construction workflow reported by Barbour et al. (2000). It was noted
in a personal communication with Steve Brill (Rutgers University, Piscataway, N.J.) that
the pJM555 plasmid that was used as the ADE3 fragment source by Barbour et al. (2000)
is now internally called pJM2555. Additional personal communications with Melanie
Dobson (Dalhousie University, Nova Scotia, Canada), Doug Koshland (University of
California, Berkeley, California), and Steve Henikoff (Fred Hutchinson Cancer Research
Center, Seattle, Washington) further corroborated the sequence of the original pSLS1 map
and its constituent gene fragments.
The sequence-complete pSLS1 map revealed an EcoRI site at position 5,605
(downstream of the SmaI cloning site at position 5,595) that was previously undocumented
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by Barbour et al. (2000). Therefore, the EcoRI double digest with SmaI that was performed
in this study was unnecessary. Besides an additional 10-bp SmaI-EcoRI fragment, a single
EcoRI digest would have produced nearly identical restriction fragments (see Figure 20).

Figure 20. A truncated segment of the sequence-complete pSLS1 map showing
the previously undocumented EcoRI site at position 5,605.
The ECM14 insert sequence produced by this study and the orientation data were
merged with the newly constructed pSLS1 map using SnapGene to produce the novel
recombinant pSLS1-ECM14 maps for both insert orientations (see Figure 21). The
orientation nomenclature of pSLS1-ECM14 was defined according to the direction of
ECM14 transcription relative to the GAL1 promotor (plus in the same direction; minus in
the opposite direction).
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Figure 21. Diagrams of the original pSLS1 vector and both orientations of the
novel pSLS1-ECM14 recombinant plasmid.
(A) The original pSLS1 plasmid contains the bacterial origin of replication
sequence (ORI), the ampicillin resistance gene (AmpR) for selection in bacteria,
the CEN/ARS sequence for replication in yeast, the URA3 gene for selection in
yeast, and the ADE3 gene for color-colony reporting (Barbour et al., 2000; Xiao,
2006). The CEN sequence is under the influence of the GAL1 galactose promotor.
(B, C) The recombinant pSLS1-ECM14 plasmids containing either ECM14 insert
orientation. Only the minus insert orientation was used for this study as this ECM14
ORF is transcribed away from the CEN/ARS region. Only plasmid features relevant
to this study are annotated (*).
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QuikChange Site-Directed Mutagenesis of ECM14
QuikChange site-directed mutagenesis (SDM) was used to introduce targeted
changes to the wild-type ECM14 ORF. Because QuikChange SDM is more efficient with
smaller plasmid constructs, the Sanger-sequenced pBluescript-ECM14 (4.8-kb) plasmid
was selected instead of the larger pSLS1-ECM14 (12.7-kb) plasmid as the template
harboring the wild-type ECM14 sequence to be mutagenized (see Table 2). QuikChange
SDM operates on the functional principles of PCR using complementary mutagenic
primers harboring 13-20 bp of homology, the mutation of interest (1-3 bp), and another 1320 bp of homology (see Table 1). Because the sense and antisense mutagenic primers are
typically complementary (3’ overhangs are generally recommended), QuikChange SDM is
inherently quite inefficient because these primers can erroneously self-anneal and produce
primer dimers. Finally, the original parent plasmid is degraded prior to transformation and
amplification in E. coli using the restriction enzyme DpnI, which selectively digests
methylated dsDNA (PCR synthesized dsDNA is not methylated) (see Figure 22).

Figure 22. The basic QuikChange site-directed mutagenesis workflow.
A parent plasmid harboring the wild-type sequence to be mutated is extended using
PCR with complementary mutagenic primers that introduce a 1-3 bp substitution.
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Three ECM14 residues were selected for QuikChange SDM: H69, H145, and K270
(see Table 3). These three residues/positions were chosen based on their conservation and
demonstratable relevance in catalytically active MCP orthologs: one selected as being
critical for zinc binding (H69), one selected for substrate binding (R145), and one selected
for catalysis (E270). The positively charged side chain of histidine (H69 and H196) is
fundamentally required for proper zinc coordination in catalytically active MCP orthologs.
Therefore, the ECM14-H69A mutant specifically disrupts this predicted zinc coordination
by substituting this histidine (H) for an alanine (A), a small and uncharged amino acid.
Because histidine and arginine (R) are both positively charged, the ECM14-H145A mutant
specifically disrupts predicted substrate binding by replacing this conserved, positively
charged residue with a small and uncharged alanine residue. Finally, because the
glutamate (E) at position 270 is required for catalysis in active MCP orthologs, the
ECM14-K270E and ECM14-K270A mutants specifically interrogate the relevance of the
lysine (K) at this position in wild-type Ecm14.
All mutagenic primers were ordered from Thermo Fisher Scientific (see Table 1)
and reconstituted with Buffer EB (10 mM Tris-Cl, pH 8.5) to 100 μM. These reconstituted
primers were further diluted to a final working concentration of 10 μM before being used
in QuikChange SDM PCR reactions. The high-fidelity Platinum SuperFi DNA Polymerase
from Invitrogen was used to perform the QuikChange SDM. A PCR master mix was
prepared for n+1 reactions (n=4) by combining 142.5 μl of sterile Milli-Q water, 50 μl of
5X SuperFi buffer, 25 μl of 2 mM dNTP mix, and 2.5 μl of SuperFi DNA Polymerase (2
U/μl). The Sanger-sequenced pBluescript-ECM14 parent plasmid stock was diluted to a
working concentration of 0.2 ng/μl (1 μl being used per SDM reaction). The amount of
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parent pBluescript-ECM14 plasmid was minimized to ensure a high mutagenesis
efficiency and thorough DpnI digestion prior to transformation. Forward and reverse
mutagenic primers were added to a final concentration of 0.5 μM. Because of the inherent
inefficiencies of QuikChange SDM, three separate attempts with varying reaction
conditions were performed in order to successfully produce the four desired ECM14
mutants. The location of each site to be mutagenized was mapped and visualized on the
pBluescript-ECM14 map using SnapGene (see Figure 23).

Figure 23. Locations for site-directed mutagenesis of pBluescript-ECM14.
The pBluescript-ECM14 plasmid was used instead of the pSLS1-ECM14 plasmid
as the template for site-directed mutagenesis due to its smaller size. Relevant primer
binding sites are annotated (H69A, H145A, K270A, and K270E). Only plasmid
features relevant to this study are shown (*).
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The first SDM attempt was performed using a non-traditional two-step thermal
cycling protocol as recommended in the SDM application note for Platinum SuperFi DNA
Polymerase. The following two-step thermal cycling profile was performed: initial
denaturation at 98°C for 30 seconds, followed by 30 cycles of denaturation at 98°C for 10
seconds and a combined annealing-extension at 72°C for 2 minutes and 40 seconds (≈ 30
sec/kb). The profile was completed with a final extension at 72°C for 5 minutes. The parent
plasmid was digested by adding 1 μl of New England Biolabs’ DpnI restriction enzyme to
each reaction and incubating in the thermal cycler heat block for 1 hour at 37°C.
The second and third SDM attempts were performed using the more traditional
three-step thermal cycling protocol. For the second SDM attempt, the following three-step
thermal cycling profile was performed: initial denaturation at 98°C for 30 seconds,
followed by 30 cycles of denaturation at 98°C for 10 seconds, annealing at 63°C for 10
seconds, and extension at 72°C for 2 minutes and 40 seconds (≈ 30 sec/kb). The profile
was completed with a final extension at 72°C for 5 minutes. Additionally, the third SDM
attempt also included 3% dimethyl sulfoxide (DMSO) in the PCR master mix to help
discourage secondary structure formation in the template DNA. Consequently, because
DMSO is known to lower primer melting temperatures, an annealing temperature of 59°C
was utilized for the third SDM attempt. Like the first SDM attempt, the parent plasmids
were digested by adding 1 μl of New England Biolabs’ DpnI restriction enzyme to each
reaction and incubating in the thermal cycler heat block for 1 hour at 37°C.
A portion of each DpnI-treated reaction (15 μl) was combined with 3 μl of New
England Biolabs’ Gel Loading Dye, Purple (6X) and ran in a 0.8% agarose gel (0.5 μg/ml
EtBr) for verification prior to transformation and amplification in E. coli. (See Figure 24).
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Figure 24. QuikChange site-directed mutagenesis of pBluescript-ECM14.
Three QuikChange SDM attempts were required to successfully produce the four
desired ECM14 mutants. The K270E mutant was successfully synthesized in the
first attempt; K270E and H145A in the second attempt; and K270A and H69A in
the third attempt (K270E and H145A were not attempted in the third attempt). PCR
reactions were treated with DpnI prior to visualization and transformation.
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Four 50-μl aliquots of Invitrogen Subcloning Efficiency DH5α Competent Cells
were slowly thawed on wet ice and each mixed with 5 μl of a DpnI-treated SDM reaction.
Each transformation mixture was incubated on wet ice for 30 minutes, heat shocked at
42°C for 45 seconds, and returned to wet ice for 5 minutes. Each reaction was incubated at
37°C for 60 minutes in 200 μl of fresh LB without ampicillin to allow for adequate
expression of the ampicillin resistance gene prior to plating. These outgrowth cultures were
subsequently plated on dry LB agar plates with ampicillin, incubated at 37°C overnight for
>20 hours, and screened for colonies. All four transformations yielded several colonies.
In order to potentially improve the effectiveness and resolution of downstream
Sanger sequencing, the Qiagen QIAprep® Spin Miniprep Kit was used instead of the
cheaper NID method for extracting and purifying each putative mutant pBluescriptECM14 plasmid. Two monoclonal colonies from each transformation plate were used to
inoculate 4 ml of LB/Amp and each culture was incubated overnight for 16-18 hours at
37°C with shaking at 250 RPM. Each overnight culture was pelleted at 6,800g for 3 minutes
and resuspended in 250 μl of Buffer P1. Each Buffer P1 suspension was mixed with 250
μl of Buffer P2 and incubated at 25°C for 4 minutes. Immediately following incubation,
these cell lysis reactions were thoroughly mixed with 350 μl of Buffer N3. Each of these
neutralized reactions were centrifuged at 17,900g for 10 minutes to pellet cellular debris.
Supernatants were transferred to a QIAprep spin column and centrifuged at 17,900g for 60
seconds. The flow-through was discarded. Each spin column was then washed with 500 μl
of Buffer PB and centrifuged at 17,900g for 60 seconds. The flow-through was discarded.
Finally, each spin column was washed with 750 μl of Buffer PE and centrifuged for
17,900g for 60 seconds. The flow-through was discarded. Any residual Buffer PE was
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thoroughly removed with an additional round of centrifugation at 17,900g for 60 seconds.
Plasmid DNA was eluted by carefully applying 50 μl of warm Buffer EB (55-65°C) to the
center of each spin column and allowing each to incubate at room temperature for >5
minutes. Each spin column was placed into a clean 1.5-ml microcentrifuge tube and
centrifuged for 90 seconds at 21,130g to elute the plasmid DNA.
Sanger sequencing was performed by GenScript (Piscataway, N.J.). The four
putative mutant pBluescript-ECM14 plasmids were sequenced using the T7, T3, and
ECM14_Internal primers (see Table 1) to ensure adequate sequencing coverage of the
ECM14 gene insert. Three sequencing samples for each plasmid were prepared by
premixing 10 μl of plasmid DNA (>50 ng/μl), 2.5 μl (50 pmol) of primer (either T7, T3, or
ECM14_Internal), and 2.5 μl of sterile Milli-Q water. Samples were shipped overnight in
1.5-ml microcentrifuge tubes sealed with Parafilm. [An initial attempt at sequencing the
putative mutant pBluescript-ECM14 plasmids was performed using the ECM14_A and
ECM14_D primers. However, these sequencing runs were inconclusive.]
Sequencing results were first processed by visually inspecting the chromatograms
using either Chromas or UGENE for base call quality and subsequently truncating any poor
terminal sequence as necessary. Each sequence was then aligned with the wild-type
ECM14 reference sequence produced by this study. Complete, end-to-end sequencing
coverage of each mutant ECM14 gene was not achieved. However, the mutagenized site
for each was successfully sequenced and, thus, provided adequate confirmation that each
of the four desired mutations were present (see Figure 25, Figure 26, and Figure 27).
Finally, each mutant ECM14 gene was subcloned into pSLS1 and the resulting insert
orientations determined using the methodology demonstrated in this study.
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Figure 25. Confirmation of successful ECM14-H69A SDM
Three putative pBluescript-ECM14-H69A plasmids were sequenced using the T7,
T3, and ECM14_Internal primers (see Table 1) to ensure adequate sequencing
coverage of the ECM14 gene insert. Only the sequence and chromatograms of the
28-30 bases around mutagenic site are shown. (A) Wild-type pBluescript-ECM14
was used as a “before SDM” control. (B) The resultant “after SDM” mutagenized
ECM14 sequence. The codon of interest is annotated in both sequences and the
resultant amino acid identified. Sanger sequencing was performed by GenScript.
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Figure 26. Confirmation of successful ECM14-H145A SDM.
Three putative pBluescript-ECM14-H145A plasmids were sequenced using the T7,
T3, and ECM14_Internal primers (see Table 1) to ensure adequate sequencing
coverage of the ECM14 gene insert. Only the sequence and chromatograms of the
28-30 bases around mutagenic site are shown. (A) Wild-type pBluescript-ECM14
was used as a “before SDM” control. (B) The resultant “after SDM” mutagenized
ECM14 sequence. The codon of interest is annotated in both sequences and the
resultant amino acid identified. Sanger sequencing was performed by GenScript.
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Figure 27. Confirmation of successful ECM14-K270[A/E] SDM.
Three putative pBluescript-ECM14-K270[A/E] plasmids were sequenced using the
T7, T3, and ECM14_Internal primers (see Table 1) to ensure adequate sequencing
coverage of the ECM14 gene insert. Only the sequence and chromatograms of the
28-30 bases around mutagenic site are shown. (A) Wild-type pBluescript-ECM14
was used as a “before SDM” control. (B, C) The resultant “after SDM”
mutagenized ECM14 sequence. The codon of interest is annotated in both
sequences and the resultant amino acid identified. Codons are reverse-complement
due to the reverse T7 primer used (*). Sanger sequencing was performed by
GenScript.
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Three minus orientations of each of the four mutant pSLS1-ECM14 plasmids were
miniprepped using the Qiagen QIAprep Spin Miniprep Kit (H69A_1, H69A_3, H69A_6;
H145A_13, H145A_14, H145A_16; K270A_1, K270A_5, K270A_6; and K270E_6,
K270E_7, K270E_11). The mutated site in each plasmid was Sanger sequenced by
Genscript using only a single primer. The ECM14_Internal primer was used to sequence
the H69A and H145A sites; and the ECM14_D primer was used to sequence the K270A
and K270E sites (see Table 1). Because the high-fidelity Platinum SuperFi DNA
Polymerase was used to perform

the original site-directed mutagenesis

in

pBluescript-ECM14, it was not necessary to re-sequence the entire mutant ECM14 gene.
However, the purpose of this final round of Sanger sequencing was simply to validate the
subcloning of each mutant ECM14 gene from pBluescript into pSLS1 (see Table 2).
The mutated sites in H145A_13, H145A_14, H145A_16, K270A_1, K207A_5, and
K270E_11 were successfully sequenced and confirmed. However, the remaining samples
were inconclusive due to failed sequencing runs that Genscript was unable to resolve by
simply tweaking the sequencing conditions and re-running these failed runs. However,
those successful mutant pSLS1-ECM14 sequences, along with the successful mutant
pBluescript-ECM14 sequences, provided confidence that the subcloning of each mutant
ECM14 sequence from pBluescript to pSLS1 was successful.
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CHAPTER 4
YEAST STRAIN CONSTRUCTION METHODS AND RESULTS
The Yeast Gene Deletion Strategy
The primary method for deleting genes in the yeast genome is the mechanism of
chromosomal integration by homologous recombination (HR) (see Figure 28). Because
point and non-sense mutations can spontaneously revert (producing so-called revertants),
removing the entire gene by HR is a more effective method for permanently deleting genes.
The first step in yeast gene deletion involves a polymerase chain reaction (PCR) in
order to amplify and extend a plasmid-borne MX sequence with 45-bp upstream and
downstream extensions flanking your favorite gene (YFG). These unique upstream and
downstream extensions are critical for ensuring that HR occurs over the intended genomic
interval. These MX “expression” cassettes also include the powerful, always-on promotor
(PTEF) and terminator (TTEF) sequence derived from the heterologous Ashbya gossyppi TEF
gene. Finally, subsequent diagnostic PCR reactions are performed in order to interrogate
both the location and the size the MX allele in the yeast genome. In general, this approach
can be used to replace any non-essential yeast gene with a variety of drug resistance (e.g.
Geneticin/Kanamycin, Nourseothricin, etc.) or autotrophic (e.g. LEU2, TRP1, URA3, etc.)
selection markers (Baudin et al., 1993; Wach et al., 1994).
The commercially available Yeast Knock-out (YKO) Collection was produced by
selectively replacing, via this process of chromosomal integration by homologous
recombination, each of the ≈5,000 non-essential genes with the Geneticin® resistance MX
cassette (KanMX). The original ecm14Δ clones used in this investigation were derived
from the YKO collection.
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Figure 28. The yeast gene deletion strategy.
The mechanism of chromosomal integration by homologous recombination. 1)
PCR is first performed in order to amplify and extend a plasmid-borne MX
sequence with 45-bp upstream and downstream extensions flanking your favorite
gene (YFG). These MX “expression” cassettes include the powerful, always-on
promotor (PTEF) and terminator (TTEF) sequence derived from the heterologous
Ashbya gossyppi TEF gene. 2) Yeast are then transformed with this deletion
cassette. 3) Finally, PCR reactions using either the A or MX_C (*) upstream
primers are performed that interrogate both the location and the size of the MX
allele in the yeast genome. (DNA features are not drawn to scale.)
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High-Fidelity PCR Amplification of [ecm14::KanMX] Cassette
The [ecm14::KanMX] deletion cassette was PCR amplified from an ecm14Δ
knockout S288C-derived yeast strain (BY4741) obtained from the Yeast Knockout
Collection (YKO) (Baker Brachmann et al., 1998). The high-fidelity Platinum SuperFi
DNA Polymerase from Invitrogen was used to amplify the [ecm14::KanMX] deletion
cassette. A PCR master mix was prepared for n+1 reactions (n=2) by combining 73 μl of
sterile Milli-Q water, 30 μl of 5X SuperFi buffer, 15 μl of 2mM dNTP mix, 2.5 μl of
ECM14_A primer, 2.5 μl of ECM14_D primer, and 2 μl of SuperFi DNA Polymerase (2
U/μl). Either 5 μl of wild-type Y1239 gDNA or ecm14Δ S288C gDNA was used as
template DNA to a final volume of 50 μl per reaction. Forward and reverse primers were
added to a final concentration of 0.5 μM. Each reaction tube was capped and carefully
mixed before placing into a Bio-Rad T100 Thermal Cycler. Forty PCR cycles were
performed using the following thermal profile: initial denaturation at 98°C for 30 seconds,
thermocycling denaturation at 98°C for 10 seconds, thermocycling annealing at 63.6°C for
10 seconds, thermocycling extension at 72°C for 60 seconds, and final extension at 72°C
for 5 minutes. Each PCR reaction was combined with 10 μl of New England Biolabs’ Gel
Loading Dye, Purple (6X) and ran in a 0.8% agarose gel (0.5 μg/ml EtBr) for visualization
and gel extraction/cleanup.
Wild-type Y1239 gDNA was used as a control and produced a single, strong 1.9kb wild-type ECM14 amplicon. The ecm14Δ knockout gDNA produced a single, strong
2.2-kb ecm14::KanMX amplicon (see Figure 29).
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Figure 29. PCR Amplification of the ecm14::KanMX deletion cassette.
The ecm14::KanMX deletion cassette was PCR amplified from an ecm14Δ
knockout S288C yeast strain obtained from the Yeast Knockout Collection (YKO).
The high-fidelity Platinum SuperFi DNA Polymerase from Invitrogen was used to
amplify the ecm14::KanMX deletion cassette (2.2 kb). Wild-type Y1239 yeast was
also used as a control (1.9 kb).
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Transformation of AF-1A/D Yeast with [ecm14::KanMX] Cassette
Fresh monoclonal colonies of either AF-1A or AF-1D (MATα and MATa,
respectively) were used to inoculate 10 ml of YEPD media (see Table 4). Liquid cultures
were incubated overnight at 30°C with shaking at 250 RPM. Cultures were grown to 12x108 cells/ml, diluted to 2x106 cells/ml in 50 ml of fresh YEPD media, and returned to
incubation at 30°C with shaking at 250 RPM for an additional 2-3 hours (≈2 cell divisions).
These diluted cultures were grown to 0.7-1.5x107 cells/ml. Each culture was then
transferred into a sterile 50-ml falcon tube and centrifuged for 5 minutes at 4,000 g. Each
pellet was then decanted, resuspended in sterile water, and centrifuged for an additional 5
minutes.
Pellets were resuspended in 1 ml of filter-sterilized 1X TE/LiAc, transferred to a
1.5-ml microcentrifuge tube, centrifuged for 6 minutes at 4,000 g, and resuspended in 250
μl of 1X TE/LiAc. Double stranded salmon sperm DNA was denatured at 100°C for 5
minutes and placed on wet ice. Yeast transformation mixtures contained 5 μl of singlestranded salmon sperm DNA, 15 μl of [ecm14::KanMX] PCR product, 50 μl of yeast
suspension, and 300 μl of 1X PEG/TE/LiAc (reagents were added in this order). Each
transformation mixture was thoroughly vortexed, incubated at 30°C for 30 minutes, and
heat-shocked at 42°C for 20 minutes. Each mixture was then briefly centrifuged at 21,130
g for 10 seconds, the PEG/TE/LiAc supernatant promptly removed, and the cells washed
in 0.5 ml of sterile water. Pellets were resuspended in fresh YEPD media and incubated at
30°C for 2 hours to allow for adequate KanMX gene expression. These outgrowth cultures
were then briefly centrifuged at 21,130 g for 10 seconds, the YEPD media removed, and
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resuspended in 100 μl of sterile water. Finally, yeasts were plated on dry YEPD agar plates
with Geneticin, incubated at 30°C for 2-3 days, and stored at 4°C.
Putative AF1-A/D [ecm14::KanMX] colonies from both transformation plates were
streaked out for single colonies onto fresh YEPD agar plates with Geneticin and incubated
at 30°C for 2-3 days. Putative monoclonal AF-1A/D [ecm14::KanMX] colonies were
grown in 1 ml YEPD overnight to mid-log phase (1-5x107 cells/ml, OD600 = 0.4-1.7).
Genomic DNA was extracted from 0.2 ml of each overnight culture. Frozen glycerol stocks
were also made by combining 0.5 ml of each overnight culture with 0.5 ml of sterile
glycerol (50% v/v) in 1-ml cryogenic storage tubes and stored at -80°C.
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Low-fidelity PCR Genotyping of Putative AF-1A/D ecm14Δ Clones
Putative AF1-A/D [ecm14::KanMX] clones were screened for both the presence of
the KanMX ORF and the absence of the ECM14 ORF using the low-fidelty DreamTaq™
DNA polymerase from Thermo Fisher Scientific. Either the upstream ECM14_A or Kan_C
upstream primer was used with the downstream ECM14_D primer (see Table 1). The
Kan_C primer is specific for the KanMX ORF and is expected to produce an 888-bp
amplicon when used with the downstream ECM14_D primer. However, the ECM14_A
and ECM14_D primers are expected to produce either an 1,894-bp amplicon in wild-type
yeast or an 2,185-bp amplicon in ecm14Δ yeast.
A PCR master mix was prepared for n+1 reactions (n=7) by combining 251.5 μl of
sterile Milli-Q water, 35 μl of 10X DreamTaq buffer, 35 μl of 2mM dNTP mix, 8.75 μl of
Kan_C primer, 8.75 μl of ECM14_D primer, and 3 μl of DreamTaq DNA polymerase (5
U/μl). An additional PCR master mix was prepared with ECM14_A and ECM14_D
primers. Either 1 μl of gDNA from AF-1A_3, AF-1D_5, AF-1D_6, or AF-1D_7 was used
as template DNA. Additionally, either 1 μl of gDNA from wild-type Y1239 or ecm14Δ
S288C were used as controls. Forward and reverse primers were added to a final
concentration of 0.2 μM. Each reaction tube was capped and carefully mixed before placing
into a Bio-Rad T100 Thermal Cycler. Forty PCR cycles were performed using the
following thermal profile: initial denaturation at 95°C for 30 seconds, thermocycling
denaturation at 95°C for 30 seconds, thermocycling annealing at 57°C for 30 seconds,
thermocycling extension at 72°C for 60 seconds, and final extension at 72°C for 5 minutes.
Each PCR reaction was combined with 10 μl of New England Biolabs’ Gel Loading Dye,
Purple (6X) and ran in a 0.8% agarose gel (0.5 μg/ml EtBr) (see Figure 30).
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Figure 30. Knock-out yeast strains were constructed using the ecm14::KanMX
deletion cassette and were verified using low-fidelity PCR.
Both mating types (AF-1A and AF1-D) were transformed using the
[ecm14::KanMX] deletion cassette and verified using PCR reactions that
interrogate both the size and the location of the KanMX allele. (A, B) Successful
ECM14 deletion can be verified by screening for a 2.2-kb KanMX amplicon or a
1.9-kb ECM14 amplicon (C). Successful ECM14 deletion can also be verified by
screening for a 0.9-kb Kan_C + ECM14_D amplicon (A, D). The YKO ecm14
knockout (Δ) was used as a Kan_C positive control. Wild-type Y1239 lack the
KanMX allele (B, D).
Those successful AF-1A/D [ecm14::KanMX] clones were streaked for single
colonies from glycerol stocks onto YEPD agar plates with Geneticin and incubated at 30°C
for 2-3 days for future transformation reactions. The successful AF-1A_3 and AF-1D_2
clones were renamed to CM-1A_3 and CM-1D_2 respectively (see Table 4).
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Transformation of CM-1A/D ecm14Δ Yeast with pSLS1-ECM14
Fresh monoclonal colonies of either CM-1A_3 [ecm14::KanMX] or CM-1D_2
[ecm14::KanMX] (MATα and MATa, respectively) were used to inoculate 10 ml of YEPD
media. Liquid cultures were incubated overnight at 30°C with shaking at 250 RPM.
Cultures were grown to 1-2x108 cells/ml, diluted to 2x106 cells/ml in 50 ml of fresh YEPD
media, and returned to incubation at 30°C with shaking at 250 RPM for an additional 2-3
hours (≈2 cell divisions). Diluted cultures were grown to 0.7-1.5x107 cells/ml. Each culture
was transferred into a sterile 50-ml falcon tube and centrifuged for 5 minutes at 4,000 g.
Each pellet was then decanted, resuspended in sterile water, and centrifuged for an
additional 5 minutes.
Pellets were resuspended in 1 ml of filter-sterilized 1X TE/LiAc, transferred to a
1.5-ml microcentrifuge tube, centrifuged for 6 minutes at 4,000 g, and resuspended in 250
μl of 1X TE/LiAc. Double stranded salmon sperm DNA was denatured at 100°C for 5
minutes and placed on wet ice. Yeast transformation mixtures contained 5 μl of singlestranded salmon sperm DNA, 2 μl of either orientation of pSLS1-ECM14, 50 μl of yeast
suspension, and 300 μl of 1X PEG/TE/LiAc (reagents were added in this order). Each
transformation mixture was thoroughly vortexed, incubated at 30°C for 30 minutes, and
heat-shocked at 42°C for 20 minutes. Each mixture was then briefly centrifuged at 21,130
g for 10 seconds, the PEG/TE/LiAc supernatant promptly removed, and washed in 0.5 ml
of sterile water. Pellets were resuspended in fresh YEPD media and incubated at 30°C for
2 hours to allow for adequate KanMX gene expression. These outgrowth cultures were
then briefly centrifuged at 21,130 g for 10 seconds, the YEPD media removed, and
resuspended in 100 μl of sterile water.
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Outgrowth cultures were plated on dry SC-Ura agar plates, incubated at 30°C for
3-4 days, and stored at 4°C. Minimal SC media lacking uracil (SC-Ura) was used to
positively select for the pSLS1-ECM14 plasmid. Additionally, growth on both YEPD and
YPGal were observed to demonstrate destabilization and loss of the plasmid when cultured
under the influence of galactose (see Figure 31).

Figure 31. Growth of CM-1A/D ecm14Δ [pSLS1-ECM14(±)] on various growth
media to demonstrate plasmid transformation and plasmid destabilization.
CM1-A/D ecm14Δ transformed with pSLS1-ECM14(±) was grown on SC-Ura,
YEPD, and YPGal. Growth on SC-Ura positively selects for the pSLS1-ECM14(±)
plasmid. Growth on YEPD and YPGal demonstrate plasmid destabilization prior to
subsequent mutagenesis experiments. Growth on YPGal effectively destabilizes the
plasmid and results in white colonies.
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CHAPTER 5
THE SYNTHETIC LETHAL SCREEN METHODS AND RESULTS
EMS Mutagenesis in Yeast
Fresh monoclonal colonies of either CM-1A_2 [pSLS1-ECM14, ecm14::KanMX]
or CM-1D_3 [pSLS1-ECM14, ecm14::KanMX] (MATα and MATa, respectively) were
used to inoculate 10 ml of SC-Ura media. Routine growth of these pre-mutagenesis strains
was performed in/on SC-Ura to ensure strong selective pressure for the pSLS1-ECM14
plasmid (see above Figure 31). Overnight cultures were adjusted to 2x108 cells/ml and 1
ml of each culture was pelleted in a clean 1.5-ml microcentrifuge at 21,130g for 10 seconds.
Pellets were washed twice in 1 ml of sterile water. After the second washing, pellets were
resuspended in 1.5 ml of sterile sodium phosphate buffer (0.1M, pH 7.0). EMS mutagenesis
was performed by combining 0.7 ml of cell suspension, 1 ml of sodium phosphate buffer,
and 50 μl of EMS in a sterile 15-ml polypropylene culture tube and incubating at 30°C for
45-60 minutes. The remaining cell suspensions were saved on wet ice as a pre-mutagenesis
control. Mutagenesis was halted by adding 0.2 ml of EMS treated cells to a sterile culture
tube containing 8 ml of sterile sodium thiosulfate solution (5% w/v). Nonmutagenized
control cells were diluted equivalently as above by substituting EMS with sterile water.
Both EMS-treated and untreated cell suspensions were serially diluted to 1-3 viable cells/μl
for plating on various growth media (100-300 viable cells per plate at 100 μl plated
volume). The EMS mutagenesis protocol used in this study was adapted from Winston
(2008); and Barbour and Xiao (2006).
Diluted EMS-treated and untreated cell suspensions were plated on various growth
media, incubated at 30°C for 2-4 days, and stored at 4°C for several days to facilitate
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adequate color development. YPD/YEPD plates were used as controls to determine the
effectiveness of EMS mutagenesis and to tune EMS exposure time in subsequent
mutagenesis attempts. An ideal EMS exposure should cause ≈40% of the cells to be killed
(Winston, 2008). An EMS exposure time of 45 minutes was determined to be effective at
generating the ideal cell death (≈40%) in the strains used in this study (see Figure 32).

Figure 32. The effect of EMS exposure time on yeast cell viability.
EMS-treated and untreated cells were plated on YPD/YEPD media to test the effect
of EMS exposure at both 60 minutes and 45 minutes. Sixty minutes of exposure
was ineffective at producing enough viable yeast cells per plate (84.3% cell death).
Reducing the EMS exposure to 45 minutes was determined to be more effective at
generating a more ideal cell death (43.6%) in the yeast strains used in this study.
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As was previously demonstrated in this study, growth on YPGal was used to
effectively destabilize the pSLS1-ECM14 plasmid and to screen for novel plasmid
dependencies (see above Figure 31). However, because the pSLS1-ECM14 plasmid
contains two additional yeast genes (ADE3 and URA3) (see above Figure 11), this
approach is fundamentally unable to immediately identity false-positive synthetic lethal
situations caused by a novel dependency on either the plasmid-borne ADE3 or URA3 genes.
Synthetic lethal situations likely require that all genes involved are transcriptionally
active. Therefore, effectively silencing either the ADE3 or URA3 gene could potentially
improve the sensitivity of the synthetic lethal screen and decrease the number of falsepositives to be subsequently evaluated. Because an active, plasmid-borne ADE3 gene is
fundamentally required for the ADE3/ADE2 color-colony assay essential to the synthetic
lethal screen, any potential modifications to decrease ADE3 false-positives were not
immediately available for use in this study. However, because the URA3 gene is not (and
should not be) involved in the synthetic lethal screen and any subsequent color-colony
assays, modifications were made in later mutagenesis attempts in order to potentially
decrease these undesirable URA3 false-positives. Because the URA3 gene is effectively
silenced when grown on media containing excess uracil, a modified YPGal media
containing extra uracil (5 ml of sterile, 0.2% uracil per liter of media) was also used for
screening EMS-treated cells.
In addition to the modification to potentially decrease URA3 false-positives, a
modified YPGal media containing 20 μg/ml, filter-sterilized calcofluor white (1000X stock
prepared at 20mg/ml) was also used for screening EMS-treated cells. Because exposure to
calcofluor white (CFW) amplifies the effect of mutations in genes involved in cell wall
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architecture and remodeling (Lussier et al., 1997; Ram et al., 1994), screening these EMStreated cells on media containing CFW was thought to increase the sensitivity of the
synthetic lethal screen to resolving novel mutations in genes that are functionally related
to ECM14. The concentration of CFW used in this modified YPGal media was based on
the standard concentration used to generate CFW hypersensitive mutants by Lussier et al.
(1997). Finally, a combination YPGal media containing both uracil and CFW was used in
the later mutagenesis attempts in order to further encourage the generation of true ECM14
synthetic lethal colonies. In either case, plates containing EMS-treated cells were screened
for non-sectored, red colonies of interest to be further studied (see Figure 33).

Figure 33. Screening EMS-treated cells on YPGal vs. YPGal+Ura+CFW.
YPGal was used to effectively destabilize the pSLS1-ECM14 plasmid and to
screen for novel plasmid dependencies. YPGal+Ura+CFW was used to discourage
the generation of URA3 false-positives and to place additional pressure on genes
thought to be functionally related to ECM14. All screening plates represented were
plated with the same number of cells at the same time. Plates containing colonies
of interest were those that contained at least one non-sectored red colony to be
further evaluated as a putative synthetic lethal.
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Screening Putative ECM14 Synthetic Lethal Mutants
Approximately 27,000 EMS-treated CM-1D ecm14Δ [pSLS1-ECM14(-)] yeast
colonies were screened for novel plasmid dependencies on galactose media (either YPGal,
YPGal+CFW, or YPGal+Ura+CFW). Three significant rounds of EMS mutagenesis were
performed, with each yielding approximately 10,000 screenable EMS-treated yeast
colonies. Colonies of interest were those that initially produced the desired non-sectored
red phenotype on these media. These non-sectored red colonies of interest were noted and
re-streaked for single colonies on fresh media to further evaluate the development and the
maintenance of the desired non-sectored red phenotype. Colonies that initially appeared as
white or sectored on galactose media were those that likely did not contain synthetic lethal
mutations and, thus, were not considered for further evaluation.
As recommended by Barbour and Xiao (2006), additional rounds of growth tests
on both SC-Ura and SC+5FOA were attempted in order to test for true synthetic lethal
mutants caused by novel secondary mutations or for potential false-positives caused by
reversions of marker genes. True synthetic lethal mutants fundamentally require the
plasmid for survival. Therefore, counterselection against the plasmid-borne URA3 gene
using 5-FOA should result in plasmid loss and, thus, cell death for true synthetic lethal
mutants. This prescribed test was performed on the first five putative synthetic lethal
mutants (SL1-5) produced from the first significant round of EMS mutagenesis performed.
A series of spotting assays was performed using serial 1:10 dilutions of these first
five putative synthetic lethal mutants (SL1-5), one EMS-treated white non-synthetic lethal
colony, and one untreated control strain. Although these five putative synthetic lethal
mutants seemed to retain the desired phenotype when subsequently re-plated/spotted on
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YPGal, all five were unable to appreciably grow on any SC-based media. However,
because the EMS-treated white non-synthetic lethal colony (CM-1D ecm14Δ) and
untreated control strain (CM-1D ecm14Δ [pSLS1-ECM14(-)]) were able to grow on SCbased media, this apparent lack of growth of these synthetic lethal mutants seemed to have
nothing to do with either the presence or the absence of the ECM14 gene (see Figure 34).
Instead, this lack of growth seemed to be the result of the secondary mutations in these
putative synthetic lethal mutants conferring significant fitness deficiencies on these SCbased media. Therefore, these apparent fitness deficiencies suggest that counterselection
of the pSLS1-ECM14 plasmid using SC+5FOA is likely not an informative diagnostic
when assessing the quality of the putative synthetic lethal mutants produced in this study.

Figure 34. Testing five putative synthetic lethal mutants on SC-Ura and SC+5FOA.
Spotting assay on YPGal, SC-Ura, and SC+5FOA. Serial 1:10 dilutions of five
putative synthetic lethal mutants (SL1-5), one EMS-treated white, non-synthetic
lethal colony (W), and one untreated control strain (C). Plates were incubated at
30°C for ≈120 hours. Putative synthetic lethal mutants were derived from EMStreated CM-1D ecm14Δ [pSLS1-ECM14(-)] colonies initially screened on YPGal.
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All putative synthetic lethal mutants were re-streaked for single colonies on
galactose media to further evaluate the development and maintenance of the desired
phenotype. Those initial white non-synthetic lethal colonies always remained white when
re-streaked on galactose media. However, many colonies of interest that initially produced
the desired non-sectored red phenotype on these media following EMS treatment produced
a variety of patterns (so-called mosaics) when re-streaked on galactose media (see Figure
35).
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Figure 35. Re-streaking putative synthetic lethal mutants on galactose media.
Putative synthetic lethal mutants that initially produced the desired non-sectored
red phenotype were re-streaked for single colonies on galactose media to evaluate
the development and maintenance of the red phenotype. (*) Colonies that were
screened on media containing Ura+CFW. A variety of patterns were observed.
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Non-sectored red colonies from these re-streaked galactose plates were used to
inoculate 2 ml of YPD liquid culture. These cultures were incubated overnight at 30°C with
shaking at 250 RPM. Frozen glycerol stocks were prepared by combining 500 µl of 50%
(v/v) sterile glycerol and 500 µl of overnight culture in a cryovial tube and were stored
at -80°C. Several non-sectored red colonies were used to prepare frozen glycerol stocks for
multiple clones from the same re-streaked plate (see above Figure 35).
The first round of EMS mutagenesis yielded five putative synthetic lethal mutants
(SL1-5) derived from YPGal. The second round yielded two putative synthetic lethal
mutants derived from YPGal+Ura+CFW (SL6-7) and six from YPGal (SL8-13). [SL14
was discovered accidentally after rechecking EMS-screening plates that had been stored at
4°C for many weeks.] The final round yielded eight putative synthetic lethal mutants
derived from YPGal+Ura and YPGal+Ura+CFW (SL15-22). Due to both timing and
logistical constraints, only those eight putative synthetic lethal mutants from the second
round (SL6-13+14) were able to be considered for future whole-genome sequencing and
bioinformatic analysis. Three clones from each of these eight putative synthetic lethal
mutants were re-streaked in mass on YPD, YPGal+Ura, and YPGal+Ura+CFW to further
evaluate the development and maintenance of the desired phenotype prior to selection for
whole-genome sequencing (see Figure 36 and Figure 37). Seven putative synthetic lethal
mutants (SL6, SL7, SL8, SL11, SL12, SL13, and SL14) were selected for whole-genome
sequencing Those remaining eight putative synthetic lethal mutants (SL15-22) were noted
and stored for any future work relating to ECM14 using this synthetic lethal system.
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Figure 36. Re-streaking putative synthetic lethal mutants (SL6-9) for the
selection of candidates for whole-genome sequencing.
Three clones (1-3) of each putative synthetic lethal mutant (SL6-9) were re-streaked
on YPD, YPGal+Ura, and YPGal+Ura+CFW to further evaluate the development
and maintenance of the desired phenotype prior to selection for whole-genome
sequencing. An additional untreated control strain (C) (CM-1D ecm14Δ [pSLS1ECM14(-)]) was also streaked for comparison.
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Figure 37. Re-streaking putative synthetic lethal mutants (SL10-13) for the
selection of candidates for whole-genome sequencing.
Three clones (1-3) of each putative synthetic lethal mutant (SL10-13) were restreaked on YPD, YPGal+Ura, and YPGal+Ura+CFW to further evaluate the
development and maintenance of the desired phenotype prior to selection for
whole-genome sequencing. An additional untreated control strain (C) (CM-1D
ecm14Δ [pSLS1-ECM14(-)]) was also streaked for comparison.
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CHAPTER 6
BIOINFORMATICS METHODS AND RESULTS
Whole-Genome Sequencing of Seven Putative Synthetic Lethal Yeast Strains
Fresh monoclonal colonies from seven putative synthetic lethal mutants (SL6, SL7,
SL8, SL11, SL12, SL13, and SL14) and one wild-type, non-mutagenized yeast strain (all
derived from CM-1D_3[ECM14(-)], see Table 4), were cultured overnight at 30°C with
shaking in 3 ml of YEPD supplemented with 25 μl of 0.5% (w/v) filter-sterilized adenine
solution. Cultures were grown to saturation. Each overnight culture was entirely pelleted
in a clean 1.5-ml microcentrifuge tube and washed twice with sterile water. Each of the
eight microcentrifuge tubes containing yeast cell pellets were thoroughly sealed with
Parafilm and shipped on ice overnight to The Sequencing Center in Fort Collins, Colorado.
Next-generation whole-genome sequencing of all eight samples was performed by
The Sequencing Center (TSC) using the Illumina MiniSeq® platform with a targeted mean
coverage depth of ≈40-50× (see Table 5). The raw forward and reverse sequencing reads
for each sample were returned from The Sequencing Center in the ubiquitous FASTQ file
format for future bioinformatic analyses. [The FASTQ file format is the de facto standard
for storing the output of high-throughput, next-generation sequencers. The FASTQ format
stores both the biological sequence and the corresponding quality score for each called
sequence letter.] The forward and reverse reads for each sample were paired to form
contiguous reads using Geneious Prime 2019.2.3 (Kearse et al., 2012).
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W303 Genome Annotation and Reference-guided Genome Assembly
The Saccharomyces cerevisiae yeast strains constructed in this study were based
on the W303 lineage. Therefore, an annotated W303 genome was desired. [Genome
annotation is the process of identifying various genomic elements (e.g. introns, exons,
regulatory sequences, coding regions, etc.) and linking useful biological metadata to these
elements.] Although S288C and W303 are closely related, they differ enough to render
comparative analyses and variant calling inordinately noisy and problematic. Ralser et al.
(2012) reported that the W303 and S288C genomes differ in 8,133 nucleotide positions
and 799 open reading frames. Despite these notable differences and some telomeric
rearrangements (notably found on chromosome XI, XIII, and XVI), the overall landscape
and structure of the S288C and W303 genomes are very similar (Matheson et al., 2017).
The annotated S288C genome was downloaded from the NCBI Reference
Sequence (RefSeq) database (Release 97, November 2019). The W303 genome has been
thoroughly sequenced (Goodwin et al., 2015; Lang et al., 2013; Matheson et al., 2017;
Ralser et al., 2012; Song et al., 2015). Recent high quality PacBio® W303 sequencing data
(47.0× coverage) from Matheson et al. (2017) were downloaded from the NCBI GenBank
database (LYZE01000001-21). Genome annotations were transferred from each S288C
chromosome to their corresponding W303 chromosome using the BLAST-like “Annotate
From…” alignment tool in Geneious Prime 2019.2.3 (see Figure 38). In order to decrease
the computational time required to align all S288C annotation sequences against the W303
genome, each W303 chromosome was annotated using only its corresponding S288C
chromosome as the source database (instead of the entire S288C genome as the source
database). Each annotated S288C chromosome was placed in separate folders that were
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individually selected as the “Source” database when annotating each corresponding W303
chromosome. Annotations were matched using a generous similarity index of 80%.
Otherwise, the default “Annotate From…” tool parameters were used.

Figure 38. An annotated portion of W303 chromosome VIII.
An annotated portion of W303 chromosome VIII (376,500…380,500) that includes
the ECM14 gene (green) and its corresponding coding sequence (yellow). The
ECM14 CDS is found along the interval 377,832 to 376,531. Genome annotations
from the S288C RefSeq genome were matched, transferred, and merged onto the
W303 genome using Geneious Prime 2019.2.3.
Those matched annotations were subsequently merged onto the W303 genome.
Because the Geneious Prime “Annotate From…” tool only transfers annotations (and their
associated biological metadata), the underlying nucleotide sequences remained intact and
unmodified. These annotated W303 chromosomes were combined and exported as a new
Geneious sequence list representing the entire W303 genome (17 sequences: 16
chromosomes plus mitochondrial DNA) to be used in subsequent reference-guided genome
assemblies and analyses.
The paired reads for each putative synthetic lethal mutant and the wild-type, nonmutagenized control yeast strain were mapped against this annotated W303 genome using
the Geneious Prime “Map to Reference” tool to generate whole-chromosome assemblies
for each sample (see Table 5). The default “Map to Reference” tool parameters were used
(Mapper: Geneious Assembler; Sensitivity: Medium-Low Sensitivity / Fast; and Fine
Tuning: Iterate up to 5 times).
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Variant Calling, Filtering, and Analysis
Genetic variants were called on each chromosome from each sequenced sample
using the Geneious Prime “Annotate & Predict > Find Variations/SNPs…” tool (Minimum
Coverage: 3; Minimum Variant Frequency: 0.8; Maximum Variant P-Value: 10-2; and Find
Variants: Inside & Outside CDS). Because each samples’ paired reads were mapped to
the same reference chromosomes and, thus, linked in the Geneious software to the same
underlying reference sequence list in memory, Geneious automatically created unique
variant tracks for each sample that could be compared, manipulated, and visualized
simultaneously on a per-chromosome basis (see Figure 39). Some manual curation of these
automated variant calls was performed in order to eliminate either conserved variants (as
compared to the WT control sequence), variants called in uninteresting genomic regions
(e.g. between coding sequences or within telomeric sequences), or variants called in
regions of generally poor sequencing coverage.

Figure 39. Visualizing variant calls across multiple samples simultaneously.
An example multi-track visualization of variant calls across multiple sequenced
samples (WT, SL6, SL7, SL8, SL11, SL12, SL13 and SL14). This example
highlights a small portion of chromosome I (95,300…96,300) that includes the
SAW1 gene. [A conserved polymorphism was observed in this gene across all
samples (interval 95,694; A -> T; N -> I; P < 10-137).] In general, any conserved
polymorphisms were noted and ultimately disregarded as true variants of interest.
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The eight sequenced samples were originally mapped in error against the BY4741
genome (the YKO deletion strain derived from and closely related to S288C) by request to
The Sequencing Center (TSC). Because the yeast strains used in this study were derived
from the W303 strain, this initial bioinformatics work performed by TSC was
fundamentally inadequate at producing any useful variant call data. However, this work
did provide insights into the genomic divergence of these yeast strains from
BY4741/S288C. The average number of variants per chromosome from SL6, SL7, SL8,
SL11, SL12, SL13, and SL14 were calculated. Chromosome XI (with 1,739 variants) was
the most divergent and chromosome XVI (with 131 variants) was the most similar (see
Figure 40). Ralser et al. (2012) reported similar results in their study on the ancestry and
physiology of the W303 strain.

Figure 40. Comparing sequenced chromosome similarity with the S288C
genome.
The average number of automated variant calls per chromosome were determined
after mapping against the S288C genome. A significant number of automated
variant calls (>8,000) were expected when mapping against the S288C genome.
Chromosome XI (1,739 variants) was the most divergent and chromosome XVI
(131 variants) was the most similar.
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The seven sequenced putative synthetic lethal samples yielded a total of 594
variants of interest after manual curation of those automated variant calls when mapped
against the correct reference genome (W303) (see Figure 41). Mapping against the wrong
genome (S288C) produced an untenable average number of variant calls (13,659 ± 369)
(see above Figure 40). However, mapping against the correct genome (W303) decreased
the average number of automated variant calls significantly by ≈18.9× per sample (723 ±
69). Manual curation of these automated W303 variant calls further reduced this list (85 ±
31).

Figure 41. The number of variants called per sequenced sample.
Automated variant calls when mapped against the correct W303 genome (723 ±
69). Manual curation of these automated W303 variant calls yielded even fewer
variants of interest per sequenced sample (85 ± 31). Total variants of interest
identified after manual curation: 594. N=7.
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Mutant Protein Sequence Analysis Using PROVEAN
The list of identified variants was further evaluated using the public Protein
Variation Effect Analyzer (PROVEAN) server hosted by the J. Craig Venter Institute
(Choi & Chan, 2015). PROVEAN is a bioinformatics software tool for predicting whether
an amino acid sequence variation impacts the underlying biological function of the mature
protein. The automated PROVEAN workflow begins by first querying the NCBI nonredundant (nr) protein database for related sequences using BLASTp (e-value cutoff = 0.1)
and then clustering these sequences using CD-HIT (75% global sequence identity). The
top 30 CD-HIT clusters are used as the “supporting sequence set” for computing delta
alignment scores for each single or multiple amino acid variation (i.e. substitutions,
insertions, or deletions) for each related sequence. The final PROVEAN score is an average
of the per-cluster average delta alignment scores with larger clusters being weighted more
than smaller clusters.
The coding sequence (CDS) codon numbers and amino acid changes for each
variant were exported from the Geneious assemblies and reformatted in the standard
Human Genome Variation Society (HGVS) nomenclature (e.g. V251I, A174V, etc.). The
wild-type amino acid sequence for each gene was obtained from SGD YeastMine and used
as the query sequence for each PROVEAN job (Cherry et al., 2012). The predefined
PROVEAN threshold score of -2.50 was used to initially qualify variants as either being
deleterious (≤-2.50) or neutral (>-2.50). Because this predefined PROVEAN threshold
score was originally calibrated by Choi and Chan (2015) to resolve the maximum
separation between deleterious and neutral variants in human protein variants, the
distribution of PROVEAN scores of essential yeast gene variants identified in this study
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was further examined. The list of essential yeast genes was obtained from SGD and used
to filter the list of identified variants for only those essential genes. Finally, these essential
gene mutants were visually mapped using the chromoMap R package (Anand & Rodriguez
Lopez, 2020) (see Figure 42). A total of 50 mutant essential genes were identified with
PROVEAN scores less than the predefined PROVEAN baseline score (-2.50). Except for
the wild-type, non-mutagenized control yeast strain (WT), all putative synthetic lethal
mutants (SL6, SL7, SL8, SL11, SL12, SL13 and SL14) contained several mutant essential
genes (7 ± 3) with PROVEAN scores at or below the baseline score (see Table 6).

Figure 42. Mutant essential gene PROVEAN scores.
PROVEAN scores for all mutant essential genes identified in this study (N=50)
were visualized as a heatmap applied to each chromosome using the chromoMap
package for the R programming language (Anand, 2019). Shades of red indicates a
PROVEAN score lower (i.e. more “deleterious’) than the baseline score (-2.50).
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Gene Ontology (GO) Enrichment Analysis
The curated lists of putative ecm14 synthetic lethal variants identified by wholegenome sequencing for each sequenced sample (SL6, SL7, SL8, SL11, SL12, SL13, and
SL14) were further filtered across a range of PROVEAN thresholds starting at -2.50 and
decreasing in increments of 0.75 down to a final threshold of -6.25. Both the ‘GO Process’
and ‘GO Function’ ontology aspects were queried using the Saccharomyces genome
database (SGD) GO Term Finder (v0.86, July 2020) and the resulting terms merged per
sequenced sample (Ashburner et al., 2000; Boyle et al., 2004). Because several essential
genes were found to be mutated at or below the baseline threshold of -2.50, a more stringent
PROVEAN cutoff of -4.00 was chosen for the final GO analysis (see above Figure 42, see
Table 6). However, GO Term Finder queries were performed across the entire range of
PROVEAN thresholds. Additionally, the GO Term Finder input query form only supports
selecting an enrichment p-value threshold below 0.01, 0.05, or 0.1 (the default is 0.01).
However, because this is limitation solely in the GO Term Finder user interface and not in
the underlying data processing pipeline, simply replacing ‘&pvalue=0.1’ with
‘&pvalue=1’ in the resulting URL in the address bar forces the search to include all
resulting GO ontology terms. These data were recorded in a master GO spreadsheet for
easy filtering and sorting.
Genes annotated by the SGD as interacting either physically or genetically with
ADE3, ECM14, or URA3 were also used to query the SGD Go Term Finder. As before,
both the ‘GO Process’ and ‘GO Function’ ontology aspects were queried and merged.
These data were also recorded in the master GO spreadsheet. These additional GO analyses
were performed in order to compare these interacting genes with those mutated in the
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synthetic lethal assays, to further determine any likely relevance with these three plasmidborne fungal genes (ADE3, ECM14, or URA3).
Each merged GO dataset was further filtered for only those GO ontology terms with
enrichment p-values ≤ 0.5. This further trimmed the list of ontology terms to be considered
in a single-page visualization. The resulting terms were then grouped according to their
association with ADE3, ECM14, and URA3 and then sorted within each group by ascending
p-values. Any ontology terms not associated with these three genes were classified as ND,
not determined, and sorted alphabetically. Finally, enrichment p-values were converted to
-LOG10 values and these values plotted as a heatmap using conditional formatting across a
linear red-white, largest-to-smallest color gradient (see Figure 43).
Little overlap was observed between GO terms for ADE3, ECM14, and URA3,
suggesting that these genes have very distinct biochemical and biological roles. For
ECM14, the top reported GO function and process terms, found to be enriched in this gene
list compared with a list of all yeast genes (p<0.05), included terms such as vesiclemediated transport (GO:0016192), vesicle fusion (GO:0006906), lipid binding
(GO:0008289), and organelle organization (GO:0006996) (see Figure 43). These terms
are consistent with a secreted or secretory role for Ecm14 in cell wall maintenance.
For all putative synthetic lethal mutants except SL7 and SL13, some enrichment
(although not always reaching significance, p < 0.05) was found for GO terms associated
with ADE3 interacting genes. Very few of the GO terms identified for the remaining
synthetic lethal gene mutations reached a p<0.05 level of significance. In some cases,
mutations were identified in genes known to be synthetic lethal with ade3. For example,
both SL6 and SL7 presented very consistently red synthetic lethal colonies; a mutation in
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the SHM2 gene resulting in a D219N amino acid change was identified in both. Likewise,
SL11 and SL14 contained mutations in the SHM2 gene, while SL13 contained a mutation
in the SHM1 gene. Both the SHM1 and SHM2 genes are reported in the SGD to be synthetic
lethals of the ade3 gene.
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Figure 43. Gene Ontology (GO) functional enrichment analysis of interactors.
(A) Genes annotated by the Saccharomyces genome database (SGD) as interacting
either physically or genetically with ADE3, ECM14, or URA3 were analyzed by
Gene Ontology (GO). Little overlap is observed between GO terms for these three
genes. The heatmap represents P-values for enrichment of genes within particular
GO classifications. Arrowhead next to heatmap scale bar indicates 0.05. Top 25
GO terms are shown for ECM14 only. (B) GO analysis for genes identified by
whole-genome sequencing as being mutated in the indicated synthetic lethal, and
for which PROVEAN analysis surpassed a threshold of -4.0. GO terms are mapped
to those identified in the SGD for ADE3, ECM14, and URA3 interactors. All others
are listed at ND, not determined.
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CHAPTER 6
DISCUSSION
Fungi necessarily rely on a wide variety of hydrolases to break down and absorb
the materials on which they grow. Few studies have examined carboxypeptidases
expressed by fungi. Only two ascomycete metallocarboxypeptidases have been previously
identified and characterized. Several publications have examined one CPA from
Metarhizium anisopliae (Austin et al., 2011; Austin & Waugh, 2012; Joshi & St Leger,
1999), while a second related CPA from Trichophyton rubrum had also been partially
characterized (Zaugg et al., 2008). Both enzymes exhibited typical CPA-like substrate
specificity.
It is likely that Ecm14 is an inactive enzyme, or pseudoenzyme. Although it is
difficult, if not impossible, to prove the absence of a function, previous studies have been
unable to detect carboxypeptidase activity in S. cerevisiae Ecm14 using standard
chromogenic assays, and this is consistent with the substitution of critical residues within
the pseudoactive site of Ecm14.
ECM14 was previously identified through transposon mutagenesis as a gene
providing resistance to calcofluor white and thus implicated in cell wall maintenance
(Lussier et al., 1997). This ECM14 mutant, in addition to being sensitive to calcofluor
white, exhibited an increased mannose:glucose ratio and was sensitive to the effects of the
aminoglycoside antibiotic hygromycin B and the glycolipid papulacandin B, thought to
inhibit β1,3-glucan synthesis (Lussier et al., 1997). In this study of cell wall maintenance,
two yeast strains with differing sensitivity to calcofluor white were used, and the ecm14
mutant was only identified in one of these two screens. This differing sensitivity is
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consistent with our observation of strain-specific sensitivities, as mild calcofluor white
sensitivity was only detected in BY4741a cells grown long-term in one of two labs.
An understanding of the subcellular or extracellular location of a protein such as
Ecm14 can provide useful information regarding the biological function of the protein.
Although Schott (2015) was unable to identify Ecm14 in the liquid growth media of S.
cerevisiae cells expressing Ecm14-His6, this polyhistidine-tagged Ecm14 was secreted
when expressed heterologously from Sf9 insect cells. Others have shown differing results
regarding localization. One large-scale analysis of yeast GFP-fusion proteins found that
Ecm14-GFP was localized to the yeast vacuole (Huh et al., 2003). A proteomic analysis of
S. cerevisiae grown in biofilm-like mats identified Ecm14 as one of many proteins found
in the extracellular matrix, but not secreted into the medium of a liquid culture (FariaOliveira et al., 2015). These results suggest that Ecm14 likely functions within the
extracellular matrix of yeast, maybe primarily under biofilm-like conditions, or possibly
within the vacuole for the intracellular regulation of cell wall and extracellular matrix
components.
Ecm14 has been identified in studies of several pathogenic fungi in recent years,
and these studies continue to point toward a function in cell wall/extracellular matrix
remodeling. A C. albicans screen for genes involved in aggregate invasive growth, a
process related to biofilm formation, identified an ECM14 mutant showing fewer
aggregates than the wild-type (Chow et al., 2019). This hints at a role in aggregate invasion,
although the equivalent experiment performed with an S. cerevisiae ecm14Δ mutant did
not result in a phenotype (Chow et al., 2019), suggesting either a false positive in the first
screen or the use of inappropriate conditions for this assay with S. cerevisiae. A
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transcriptomics study of the plant pathogen V. dahliae showed that the expression of
Ecm14, along with a variety of cell wall degrading hydrolases, was upregulated in response
to exudates from V. dahliae-susceptible cotton roots (Zhang et al., 2020). This again points
to a possible role for Ecm14 in invasion. Finally, a recent analysis of glycosylation in the
plant pathogen M. oryzae showed that the glycosylation of Ecm14 is upregulated primarily
during mycelial growth as compared with the conidia and appressoria stages (Chen et al.,
2020). It was proposed that many proteins differentially glycosylated during mycelial
growth were involved in cell wall biogenesis and nutrient utilization (Chen et al., 2020).
Schott (2015) found that Ecm14 expressed in S. cerevisiae was also glycosylated, although
the function of this modification was not further examined.
The above studies indicating a role for Ecm14 in fungal growth and pathogenesis
lend support to this study in which Ecm14 is shown to be highly conserved across the
ascomycete lineage (see Figure 45). These aspects of fungal growth are important to
understand as we try to counteract the pathogenic effects of many fungi. An analysis of all
reported interactions with ECM14 supports the likelihood that a functional secretory
pathway and other aspects of organellar trafficking are required for Ecm14 function.
Unfortunately, attempts to further identify redundant pathways through a synthetic lethal
approach suggested that redundant pathways were many, such that a single-gene synthetic
lethal clone from the analysis of nearly 30,000 mutants was unable to be isolated, or that
Ecm14 was not required in the conditions and cells examined during these assays.
It could be that a clear phenotype for S. cerevisiae ecm14 mutants has not yet been
identified because most yeast that are used in the lab are unable to effectively form
aggregates. Scientists have effectively selected against this phenotype to make yeast
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genetics simpler. The data suggests that, while Ecm14 may not be required in many
laboratory strains of S. cerevisiae, Ecm14 is a conserved and important pseudoenzyme
within many fungal species that exists in zymogen form until activated by a trypsin-like
endopeptidase, whereupon it likely functions in cell wall maintenance and/or fungal
invasion.
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APPENDIX A
TABLES
Table 1. PCR primers used in this study.
Name

nt

GC
%

Sequence (5’ to 3’)

T7

20

40.0

TAATACGACTCACTATAGGG

T3

21

42.9

GCAATTAACCCTCACTAAAGG

ECM14_A

25

36.0

ATTTTAGTTCTTGTGGTGACAGCTT

ECM14_D

25

36.0

AATCACTAAAAAGGAGATGAAGCCT

ECM14_A-BamHI

35

37.1

(TATA)[GGATCC]ATTTTAGTTCTTGTGGTGACAGCTT

ECM14_D-BamHI

35

37.1

(TATA)[GGATCC]AATCACTAAAAAGGAGATGAAGCCT

ECM14_Internal

20

50.0

GCAGATAAATGATGGGCAGG

Kan_C (KanC)

22

36.4

TGATTTTGATGACGAGCGTAAT

ECM14_H69A-for

28

57.1

CACAGGTGGTATA{GC}TGCCAGAGAGTGG

ECM14_H69A-rev

28

57.1

CCACTCTCTGGCA{GC}TATACCACCTGTG

ECM14_H145A-for

30

43.3

GTATCGACATTGAT{GC}TTCCTTTGGTTTCC

ECM14_H145A-rev

30

43.3

GGAAACCAAAGGAA{GC}ATCAATGTCGATAC

ECM14_K270A-for

30

53.3

GGGCATTCCAGTTG{GC}ATTACGGGATACAG

ECM14_K270A-rev

30

53.3

CTGTATCCCGTAAT{GC}CAACTGGAATGCCC

ECM14_K270E-for

30

50.0

CTGTATCCCGTAATT{C}CAACTGGAATGCCC

ECM14_K270E-rev

30

50.0

GGGCATTCCAGTTG{G}AATTACGGGATACAG

() denote restriction enzyme sitting sequence.
[] denote restriction enzyme recognition sequence.
{} denote mutagenic substitution sites.
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Table 2. Plasmids constructed and used in this study.
Name

Kb

Insert

Features

Source

Reference

pBluescript II SK+

3.0

--

AmpR, LacZα, ORI

Peter J.
Lyons

Alting-Mees and
Short, 1989

pRS316

4.9

--

AmpR, CEN4/ARS1, LacZα,
ORI, URA3

Melanie J.
Dobson

Sikorski and
Hieter, 1989

pAG25

3.7

--

AmpR, NatMX, ORI

Peter J.
Lyons

Goldstein et al.,
1999

pSLS1

10.8

--

ADE3, AmpR, CEN4/ARS1,
ORI, URA3, pGAL1

Melanie J.
Dobson

Barbour et al.,
2000

pRS316-NatMX

6.2

NatMX

AmpR, CEN4/ARS1, LacZα,
ORI, URA3

This study

--

pBluescript-ECM141

4.8

ECM14

AmpR, LacZα, ORI

This study

--

-H69A1

4.8

-H69A

AmpR, LacZα, ORI

This study

--

-H145A1

4.8

-H145A

AmpR, LacZα, ORI

This study

--

-K270A1

4.8

-K270A

AmpR, LacZα, ORI

This study

--

-K270E1

4.8

-K270E

AmpR, LacZα, ORI

This study

--

ADE3, AmpR, CEN4/ARS1,
ORI, URA3, pGAL1

This study

--

pSLS1-ECM141

1

12.7

ECM14

-H69A1

12.7

-H69A

ADE3, AmpR, CEN4/ARS1,
ORI, URA3, pGAL1

This study

--

-H145A1

12.7

-H145A

ADE3, AmpR, CEN4/ARS1,
ORI, URA3, pGAL1

This study

--

-K270A1

12.7

-K270A

ADE3, AmpR, CEN4/ARS1,
ORI, URA3, pGAL1

This study

--

-K270E1

12.7

-K270E

ADE3, AmpR, CEN4/ARS1,
ORI, URA3, pGAL1

This study

--

Both insert orientations were constructed. The minus orientation was used in this study.
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Table 3. Three conserved positions mutated in ECM14 using QuikChange SDM.

1

Role (Position1)

M14 MCPs

ECM14

-H69A

Zinc Binding (69)

His/H,
(Positive)

His/H,
Positive

Ala/A,
(Nonpolar)

Substrate Binding (145)

Arg/R,
Positive

His/H,
Positive

Catalysis (270)

Glu/E,
Negative

Lys/K,
Positive

-H145A

-K270E

-K270A

Glu/E,
(Negative)

Ala/A,
(Nonpolar)

Ala/A,
(Nonpolar)

Relative to the mature polypeptide sequence of bovine CPA1.
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Table 4. Yeast strains used in this study.
Name

Background

Genotype

Source

Y1239

--

MATa {ura3-52 lys2-801 ade2-101 trpl-1 his3-200
TUB4::3XHA, URA3}

Peter J.
Lyons

YHR132C∆

BY4741/2

MATa/α {leu2Δ met15Δ ura3Δ ecm14::KanMX}

Peter J.
Lyons

AF-1A

W303

MATα {ade2-1 ura3-1 leu2-3,-112 his3-11,-15
trp1-1 ade3∆}

Melanie J.
Dobson

AF-1D

W303

MATa {ade2-1 ura3-1 leu2-3,-112 his3-11,-15
trp1-1 ade3∆}

Melanie J.
Dobson

CM-1A_2

AF-1A (W303)

MATα {ade2-1 ura3-1 leu2-3,-112 his3-11,-15
trp1-1 ade3∆ ecm14::KanMX}

This study

CM-1D_3

AF-1D (W303)

MATa {ade2-1 ura3-1 leu2-3,-112 his3-11,-15
trp1-1 ade3∆ ecm14::KanMX}

This study

CM-1A_2[ECM14]1

AF-1A (W303)

MATα {ade2-1 ura3-1 leu2-3,-112 his3-11,-15 trp1-1
ade3∆ ecm14::KanMX} [pSLS1-ECM14]*

This study

CM-1D_3[ECM14]1

AF-1D (W303)

MATa {ade2-1 ura3-1 leu2-3,-112 his3-11,-15 trp1-1
ade3∆ ecm14::KanMX} [pSLS1-ECM14]*

This study

CM-1A[NAT]

AF-1A (W303)

MATα {ade2-1 ura3-1 leu2-3,-112 his3-11,-15 trp1-1
ade3∆} [pRS316-NatMX]

This study

1

Both insert orientations were constructed. The minus orientation was used in this study.
{ } denote genomic-based features.
[ ] denote plasmid-based features.
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Table 5. Whole-genome sequencing using the Illumina MiniSeq® platform.
Sample

Bases Read

Paired Reads

Matched Reads

Read Length
x̄ (σ)

Coverage
x̄

GC
%

WT

878,377,752

5,997,874

4,899,419 (81.7%)

146.4 (15.7)

56.8

41.0

SL6

581,444,805

3,959,960

3,216,531 (80.6%)

146.8 (15.7)

36.9

41.0

SL7

494,730,687

3,451,230

2,746,783 (79.6%)

143.3 (19.6)

31.6

40.8

SL8

634,384,283

4,321,856

3,626,739 (83.9%)

146.8 (15.3)

42.5

40.5

SL11

633,162,416

4,309,744

3,721,436 (86.3%)

146.9 (15.2)

43.5

40.4

SL12

743,482,836

5,087,184

4,611498 (90.6%)

146.1 (16.2)

53.3

40.4

SL13

618,472,666

4,215,912

3,744,904 (88.8%)

146.7 (16.1)

44.3

40.5

SL14

561,659,729

3,869,674

3,400,631 (87.9%)

145.1 (17.9)

39.2

40.6

5,145,715,174

35,213,434

29,967,941 (85.1%)

Σ
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Table 6. Mutant essential genes identified in this study.

1

Variant

PROVEAN

SL

ARC19 (YKL013C)

7

E37K

-3.838

PRP8 (YHR165C)

6

E204K

-3.563

ARH1 (YDR376W)

14

S119N

-3.000

PSE1 (YMR308C)

14

D324N

-5.000

ARP5 (YNL059C)

13

G129R

-4.940

REA1 (YLR106C)

6

L2361F

-2.526

BRR2 (YER172C)

12

A2113T

-3.080

RET3 (YPL010W)

12

G19R

-7.279

BRR2 (YER172C)

8

S51F

-5.146

ROM2 (YLR371W)

13

A1293T

-3.540

CFT1 (YDR301W)

13

N1072Y

-7.500

RPA135 (YPR010C)

12

P951L

-9.250

COP1 (YDL145C)

11

G54S

-5.978

RPB2 (YOR151C)

12

C829Y

-9.421

CYR1 (YJL005W)

12

G1471D

-5.887

RPG1 (YBR079C)

6

A582T

-2.555

EXO84 (YBR102C)

14

P92S

-2.652

SEC7 (YDR170C)

8

S322F

-2.719

FHL1 (YPR104C)

11

T647M

-5.400

SLY1 (YDR189W)

13

S91F

-3.537

GCD6 (YDR211W)

14

R120K

-2.980

SLY1 (YDR189W)

13

S130L

-5.365

GUS1 (YGL245W)

8

A222T

-4.000

SMC2 (YFR031C)

7

A168T

-3.996

ILV3 (YJR016C)

12

P148L

-9.701

SMC3 (YJL074C)

14

A1141T

-3.967

ILV3 (YJR016C)

7

G454D

-5.304

SOG2 (YOR353C)

13

G227E

-6.911

KIN28 (YDL108W)

13

E84K

-3.989

SSC1 (YJR045C)

14

A281T

-3.970

MET30 (YIL046W)

11

G590S

-3.015

STH1 (YIL126W)

13

T408I

-5.967

MOT1 (YPL082C)

11

P1265S

-7.933

STT4 (YLR305C)

14

A662T

-3.311

MSS4 (YDR208W)

11

P432L

-9.567

SUA5 (YGL169W)

12

A208V

-4.000

NET1 (YJL076W)

8

E107K

-3.133

TAM41 (YGR046W)

8

G129S

-3.200

NFS1 (YCL017C)

12

V401M

-2.647

TIF34 (YMR146C)

12

P143L

-6.270

NOP15 (YNL110C)

14

S131F

-5.750

TOR2 (YKL203C)

11

P434L

-6.408

NOP8 (YOL144W)

13

R174S

-3.733

TRL1 (YJL087C)

14

R352K

-3.000

PAN1 (YIR006C)

8

R635C

-7.952

TRR1 (YDR353W)

12

G130C

-8.827

PCM1 (YEL058W)

11

G233D

-6.965

TRS120 (YDR407C)

14

P935S

-3.715

PRP6 (YBR055C)

8

P734S

-5.639

UTP20 (YBL004W)

13

D517N

-3.428

Score1

Gene/ORF Name

SL

Variant

PROVEAN

Gene/ORF Name

Score1

-2.50 PROVEAN threshold was used to qualify deleterious (≤) or neutral (>) variants.
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SUPPLEMENTAL FIGURES

Figure 44. The functional rescue assay workflow.
(1) A diploid yeast strain is produced by crossing a wild-type haploid [pRS316NatMX] strain with a haploid synthetically lethal strain (gene-y, ecm14::KanMX).
Diploids are selected for by growth on YPD/G418/NTC. (2) Growth on SC+5FOA
allows for selection against the now unnecessary pRS316-NatMX and pSLS1ECM14 plasmids. (3) Cells are transformed with the pSLS1 or pSLS1-ECM14
plasmids followed by (4) random sporulation and germination of these haploid
spores on YPGal.
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Figure 45. Ecm14 is conserved in Ascomycota, but not in other fungal phyla.
BLASTp was performed with bovine CPA1 as the query sequence and all fungal
sequences as the search set. 2068 sequences of 150 amino acids or longer that
contained the majority of the carboxypeptidase domain were identified and aligned
using Clustal Omega. The resulting tree is shown, containing three predominant
groups consistent with CPB-like, CPA-like, and Ecm14-like properties. Sequences
from basal fungi are shown in pink. CPB sequences from ascomycetes are shown
in dark red, with co-clustering sequences lacking the required Asp at position 255
shown in a lighter red. CPA-like sequences, mostly from ascomycetes, are shown
in blue. Ecm14 sequences, all from ascomycetes, are shown in dark green, with a
sister clade of Ecm14-like proteins from basidiomycetes, and with unique and
conserved ‘active’ site residues, shown in cyan and light green. Ecm14 proteins are
defined by the presence of N144D and E270K substitutions.
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APPENDIX B
DIRECT SELECTION OF YEAST DIPLOIDS
Subcloning the NatMX Allele From pAG25 into pRS316
The original yeast strains used in this study are isogenic and, thus, lack
complementary recessive auxotrophic markers typically used for the routine selection of
diploids from mating reactions (see above Table 4). Furthermore, these autotrophies can
impair yeast growth and interfere with downstream methods like sporulation (Sadowski et
al., 2008). Thus, alternative methods for selecting diploids can be desirable. In order to
facilitate both the direct selection and stable propagation of diploids strains produced in
this study, an additional yeast plasmid harboring a unique drug-resistance marker was
constructed. By mating haploid yeast strains that each harbor a unique drug-resistance
marker (e.g. NatMX and KanMX), it is possible to directly select for diploids on media
containing a combination of these two drugs (e.g. NTC and G418). Only those diploids
containing both markers can survive on this selection media (see Figure 46).

Figure 46. The direct selection of diploids using multiple drug-resistance markers.
Mating haploid yeast strains that each harbor a unique drug-resistance marker
produces diploids that can grow on media containing both drugs. Because the
parental haploids each lack one of these drug-resistance markers, these haploids are
unable to survive on this media.
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The dominant NatMX allele from the pAG25 plasmid was subcloned into the yeast
shuttle vector pRS316 (see above Table 2). The pAG25 plasmid alone is only useful as a
template for PCR to create gene deletion cassettes and, thus, lacks the CEN4/ARS1
sequences required for replication in yeast. An ample amount of both pAG25 and pRS316
were thoroughly digested with BamHI and EcoRI to ensure adequate recovery yields for
future downstream applications. 15 μl of either pAG25 or pRS316 was combined with 28
μl of sterile Milli-Q water, 5 μl of CutSmart Buffer,1 μl of BamHI-HF enzyme, and 1 μl of
EcoRI-HF enzyme. Both digestion reactions were allowed to incubate for 2 hours at 37°C.
Both digestion reactions were subsequently electrophoresed in a 0.8% agarose gel (0.5
μg/ml EtBr) for 60 minutes to allow for separation of the pAG25 (2,465 bp) and NatMX
(1,239 bp) bands.
The pRS316 and NatMX bands were both gel extracted using the modified protocol
for large DNA fragments, ran in an additional 0.8% agarose gel (0.5 μg/ml EtBr), and
quantified using ImageJ. The pRS316-NatMX ligation reaction was performed overnight
at 16°C with a 1:3 vector-to-insert ratio. This ligation reaction contained 0.5 μl of pRS316BamHI-EcoRI (44.62 ng/μl, 0.014 pmol), 13 μl of NatMX-BamHI-EcoRI (2.68 ng/μl,
0.043 pmol), 3.5 μl of sterile Milli-Q water, 2 μl of T4 DNA Ligase Buffer, and 1 μl of T4
DNA Ligase.
One 50-μl aliquot of Invitrogen Max Efficiency DH5α was slowly thawed on wet
ice and gently mixed with 5 μl of the overnight pRS316-NatMX ligation reaction. This
transformation mixture was incubated on wet ice for 30 minutes, heat shocked at 42°C for
45 seconds, and returned to wet ice for 2 minutes. The transformation mixture was
incubated for 60 minutes at 37°C in 450 μl of fresh SOC without ampicillin to allow for
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adequate expression of the ampicillin resistance gene prior to plating. This outgrowth
culture was subsequently plated on dry IPTG/X-Gal LB agar plates (250 μl/plate) with
ampicillin and incubated at 37°C overnight for >20 hours.
Four putative pRS316-NatMX colonies (white) were cultured overnight and
miniprepped using the NID method and digested with BamHI-HF and EcoRI-HF at 37°C
for 60 minutes. Each of these diagnostic digests included 5 μl of plasmid DNA, 12 μl of
sterile Milli-Q water, 2 μl of CutSmart Buffer, and 1 μl of BamHI-HF enzyme. Each digest
was ran in a 0.8% agarose gel (0.5 μg/ml EtBr) and imaged using the AlphaImager HP gel
imaging system (see Error! Reference source not found.). Only those digests that clearly l
iberated both a pRS316 band (4.9-kb) and a NatMX band (1,239-bp) were considered for
further interrogation. A map of the pRS316-NatMX plasmid was constructed using
SnapGene (see Figure 48). Diploid selection using the pRS316-NatMX plasmid was
demonstrated using the yeast strains relevant to this study (see Figure 49).

Figure 47. Subcloning of NatMX from pAG25 into pRS316.
The NatMX gene was subcloned from the pAG25 (3.7 kb) parent plasmid into the
pRS316 (4.9 kb) destination vector. The pAG25 parent plasmid and pRS316
destination vector were double digested with BamH1 and EcoRI. T4 DNA ligase
was used to ligate the NatMX insert into pRS316. Four putative pRS316-NatMX
preparations were digested with BamHI and EcoRI. Only those digests that clearly
liberated both a pRS316 band (4.9 kb) and a NatMX band (1.2 kb) were considered
for further interrogation.
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Figure 48. Diagrams of the pAG25 plasmid, the pRS316 shuttle vector, and the
recombinant pRS316-NatMX plasmid.
(A) The pAG25 plasmid was the source of the NatMX expression cassette. (B) The
pRS316 plasmid is able to replicate in both bacteria (high-copy) and yeast (singlecopy). (C) The recombinant pRS316-NatMX plasmid. Only plasmid features
relevant to this study are shown (*).

123

Figure 49. Selecting diploids using the pRS316-NatMX plasmid.
A basic proof-of-concept demonstrating the direct selection of yeast diploids using
two unique drug-resistance markers and selective growth media containing a
combination of two drugs. Haploid control yeast (MATα and MATa) were streaked
on this YPD+G418+NTC media. Diploids were mated by mixing both mating types
on a YPD plate (without drugs) and incubating overnight at 30°C. This overnight
mating reaction was resuspended in 1ml of sterile water, diluted 100X, and plated
on this YPD+G418+NTC media.

124

REFERENCE LIST
Adrain, C., & Freeman, M. (2012). New lives for old: evolution of pseudoenzyme
function illustrated by iRhoms. Nat Rev Mol Cell Biol, 13(8), 489-498.
doi:10.1038/nrm3392
Aguiar, T. Q., Silva, R., & Domingues, L. (2015). Ashbya gossypii beyond industrial
riboflavin production: A historical perspective and emerging biotechnological
applications. Biotechnol Adv, 33(8), 1774-1786.
doi:10.1016/j.biotechadv.2015.10.001
Aguilar-Uscanga, B., & Francois, J. M. (2003). A study of the yeast cell wall
composition and structure in response to growth conditions and mode of
cultivation. Lett Appl Microbiol, 37(3), 268-274. doi:10.1046/j.1472765x.2003.01394.x
Aliouat-Denis, C. M., Chabe, M., Demanche, C., Aliouat el, M., Viscogliosi, E., Guillot,
J., Delhaes, L., & Dei-Cas, E. (2008). Pneumocystis species, co-evolution and
pathogenic power. Infect Genet Evol, 8(5), 708-726.
doi:10.1016/j.meegid.2008.05.001
Alsters, S. I. M., Goldstone, A. P., Buxton, J. L., Zekavati, A., Sosinsky, A., Yiorkas, A.
M., Holder, S., Klaber, R. E., Bridges, N., van Haelst, M. M., le Roux, C. W.,
Walley, A. J., Walters, R. G., Mueller, M., & Blakemore, A. I. F. (2015).
Truncating Homozygous Mutation of Carboxypeptidase E (CPE) in a Morbidly
Obese Female with Type 2 Diabetes Mellitus, Intellectual Disability and
Hypogonadotrophic Hypogonadism. PLOS ONE, 10(6), e0131417.
doi:10.1371/journal.pone.0131417
Anand, L., & Rodriguez Lopez, C. M. (2020). chromoMap: An R package for Interactive
Visualization and Annotation of Chromosomes. bioRxiv, 605600.
doi:10.1101/605600
Arolas, J. L., Vendrell, J., Aviles, F. X., & Fricker, L. D. (2007).
Metallocarboxypeptidases: emerging drug targets in biomedicine. Curr Pharm
Des, 13(4), 349-366. doi:10.2174/138161207780162980
Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A.
P., Dolinski, K., Dwight, S. S., Eppig, J. T., Harris, M. A., Hill, D. P., IsselTarver, L., Kasarskis, A., Lewis, S., Matese, J. C., Richardson, J. E., Ringwald,
M., Rubin, G. M., & Sherlock, G. (2000). Gene ontology: tool for the unification
of biology. The Gene Ontology Consortium. Nat Genet, 25(1), 25-29.
doi:10.1038/75556
Auld, D. (2004). Catalytic mechanisms of metallopeptidases. Handbook of Proteolytic
Enzymes, 268-289.
Austin, B. P., Tozser, J., Bagossi, P., Tropea, J. E., & Waugh, D. S. (2011). The substrate
specificity of Metarhizium anisopliae and Bos taurus carboxypeptidases A:
insights into their use as tools for the removal of affinity tags. Protein Expr Purif,
77(1), 53-61. doi:10.1016/j.pep.2010.11.005
Austin, B. P., & Waugh, D. S. (2012). Isolation of Metarhizium anisopliae
carboxypeptidase A with native disulfide bonds from the cytosol of Escherichia
coli BL21(DE3). Protein Expr Purif, 82(1), 116-124.
doi:10.1016/j.pep.2011.11.015
125

Baker Brachmann, C., Davies, A., Cost, G. J., Caputo, E., Li, J., Hieter, P., & Boeke, J.
D. (1998). Designer deletion strains derived from Saccharomyces cerevisiae
S288C: A useful set of strains and plasmids for PCR-mediated gene disruption
and other applications. Yeast, 14(2), 115-132. doi:10.1002/(SICI)10970061(19980130)14:2<115::AID-YEA204>3.0.CO;2-2
Barbour, L., & Xiao, W. (2006). Synthetic lethal screen. Methods Mol Biol, 313, 161169. doi:10.1385/1-59259-958-3:161
Barbour, L., Zhu, Y., & Xiao, W. (2000). Improving synthetic lethal screens by
regulating the yeast centromere sequence. Genome, 43(5), 910-917. Retrieved
from https://www.ncbi.nlm.nih.gov/pubmed/11081983
Baudin, A., Ozier-Kalogeropoulos, O., Denouel, A., Lacroute, F., & Cullin, C. (1993). A
simple and efficient method for direct gene deletion in Saccharomyces cerevisiae.
Nucleic acids research, 21(14), 3329-3330. doi:10.1093/nar/21.14.3329
Bergthorsson, U., Andersson, D. I., & Roth, J. R. (2007). Ohno's dilemma: evolution of
new genes under continuous selection. Proc Natl Acad Sci U S A, 104(43), 1700417009. doi:10.1073/pnas.0707158104
Birdsell, J., & Wills, C. (2003). The Evolutionary Origin and Maintenance of Sexual
Recombination: A Review of Contemporary Models. Evol. Biol., 33, 27-138.
doi:10.1007/978-1-4757-5190-1_2
Blobel, C. P., Carpenter, G., & Freeman, M. (2009). The role of protease activity in ErbB
biology. Exp Cell Res, 315(4), 671-682. doi:10.1016/j.yexcr.2008.10.011
Bordallo, J., & Suarez-Rendueles, P. (1993). Control of Saccharomyces cerevisiae
carboxypeptidase S (CPS1) gene expression under nutrient limitation. Yeast, 9(4),
339-349. doi:10.1002/yea.320090404
Boyle, E. I., Weng, S., Gollub, J., Jin, H., Botstein, D., Cherry, J. M., & Sherlock, G.
(2004). GO::TermFinder--open source software for accessing Gene Ontology
information and finding significantly enriched Gene Ontology terms associated
with a list of genes. Bioinformatics, 20(18), 3710-3715.
doi:10.1093/bioinformatics/bth456
Boynton, P. J., & Greig, D. (2014). The ecology and evolution of non-domesticated
Saccharomyces species. Yeast, 31(12), 449-462. doi:10.1002/yea.3040
Brookes, P., & Lawley, P. D. (1961). The reaction of mono- and di-functional alkylating
agents with nucleic acids. Biochem J, 80(3), 496-503. doi:10.1042/bj0800496
Chen, X.-L., Liu, C., Tang, B., Ren, Z., Wang, G.-L., & Liu, W. (2020). Quantitative
proteomics analysis reveals important roles of N-glycosylation on ER quality
control system for development and pathogenesis in Magnaporthe oryzae. PLOS
Pathogens, 16(2), e1008355. doi:10.1371/journal.ppat.1008355
Cherry, J. M., Hong, E. L., Amundsen, C., Balakrishnan, R., Binkley, G., Chan, E. T.,
Christie, K. R., Costanzo, M. C., Dwight, S. S., Engel, S. R., Fisk, D. G.,
Hirschman, J. E., Hitz, B. C., Karra, K., Krieger, C. J., Miyasato, S. R., Nash, R.
S., Park, J., Skrzypek, M. S., Simison, M., Weng, S., & Wong, E. D. (2012).
Saccharomyces Genome Database: the genomics resource of budding yeast.
Nucleic Acids Res, 40(Database issue), D700-705. doi:10.1093/nar/gkr1029
Choi, Y., & Chan, A. P. (2015). PROVEAN web server: a tool to predict the functional
effect of amino acid substitutions and indels. Bioinformatics (Oxford, England),
31(16), 2745-2747. doi:10.1093/bioinformatics/btv195
126

Chow, J., Dionne, H. M., Prabhakar, A., Mehrotra, A., Somboonthum, J., Gonzalez, B.,
Edgerton, M., & Cullen, P. J. (2019). Aggregate Filamentous Growth Responses
in Yeast. mSphere, 4(2). doi:10.1128/mSphere.00702-18
Chuang, J. S., & Schekman, R. W. (1996). Differential trafficking and timed localization
of two chitin synthase proteins, Chs2p and Chs3p. J Cell Biol, 135(3), 597-610.
doi:10.1083/jcb.135.3.597
Clarke, L., & Carbon, J. (1980). Isolation of a yeast centromere and construction of
functional small circular chromosomes. Nature, 287(5782), 504-509.
doi:10.1038/287504a0
Dobzhansky, T. (1946). Genetics of natural populations; recombination and variability in
populations of Drosophila pseudoobscura. Genetics, 31, 269-290. Retrieved from
https://www.ncbi.nlm.nih.gov/pubmed/20985721
Duina, A. A., Miller, M. E., & Keeney, J. B. (2014). Budding yeast for budding
geneticists: a primer on the Saccharomyces cerevisiae model system. Genetics,
197(1), 33-48. doi:10.1534/genetics.114.163188
Dunham, M. J., & Louis, E. J. (2011). Yeast evolution and ecology meet genomics.
EMBO Rep, 12(1), 8-10. doi:10.1038/embor.2010.204
Dutt, A., Canevascini, S., Froehli-Hoier, E., & Hajnal, A. (2004). EGF signal propagation
during C. elegans vulval development mediated by ROM-1 rhomboid. PLoS Biol,
2(11), e334. doi:10.1371/journal.pbio.0020334
Eaton, D. L., Malloy, B. E., Tsai, S. P., Henzel, W., & Drayna, D. (1991). Isolation,
molecular cloning, and partial characterization of a novel carboxypeptidase B
from human plasma. J Biol Chem, 266(32), 21833-21838. Retrieved from
https://www.ncbi.nlm.nih.gov/pubmed/1939207
Engel, S. R., Dietrich, F. S., Fisk, D. G., Binkley, G., Balakrishnan, R., Costanzo, M. C.,
Dwight, S. S., Hitz, B. C., Karra, K., Nash, R. S., Weng, S., Wong, E. D., Lloyd,
P., Skrzypek, M. S., Miyasato, S. R., Simison, M., & Cherry, J. M. (2014). The
reference genome sequence of Saccharomyces cerevisiae: then and now. G3
(Bethesda), 4(3), 389-398. doi:10.1534/g3.113.008995
Eriksson, O. E., & Winka, K. (1997). Supraordinal taxa of Ascomycota. Myconet, 1, 16.
Eyers, P. A., & Murphy, J. M. (2013). Dawn of the dead: protein pseudokinases signal
new adventures in cell biology. Biochem Soc Trans, 41(4), 969-974.
doi:10.1042/BST20130115
Eyers, P. A., & Murphy, J. M. (2016). The evolving world of pseudoenzymes: proteins,
prejudice and zombies. BMC Biol, 14(1), 98. doi:10.1186/s12915-016-0322-x
Ezihe-Ejiofor, J. A., & Hutchinson, N. (2013). Anticlotting mechanisms 1: physiology
and pathology. Continuing Education in Anaesthesia Critical Care & Pain, 13(3),
87-92. doi:10.1093/bjaceaccp/mks061
Faria-Oliveira, F., Carvalho, J., Ferreira, C., Hernáez, M. L., Gil, C., & Lucas, C. (2015).
Quantitative differential proteomics of yeast extracellular matrix: there is more to
it than meets the eye. BMC microbiology, 15, 271-271. doi:10.1186/s12866-0150550-1
Ferguson, B. A., Dreisbach, T. A., Parks, C. G., Filip, G. M., & Schmitt, C. L. (2003).
Coarse-scale population structure of pathogenic Armillaria species in a mixedconifer forest in the Blue Mountains of northeast Oregon. Canadian Journal of
Forest Research, 33(4), 612-623. doi:10.1139/x03-065
127

Fesel, P. H., & Zuccaro, A. (2016). β-glucan: Crucial component of the fungal cell wall
and elusive MAMP in plants. Fungal Genetics and Biology, 90, 53-60.
doi:https://doi.org/10.1016/j.fgb.2015.12.004
Force, A., Lynch, M., Pickett, F. B., Amores, A., Yan, Y. L., & Postlethwait, J. (1999).
Preservation of duplicate genes by complementary, degenerative mutations.
Genetics, 151(4), 1531-1545. Retrieved from
https://www.ncbi.nlm.nih.gov/pubmed/10101175
Fricker, L. D. (2018). Carboxypeptidase E and the Identification of Novel Neuropeptides
as Potential Therapeutic Targets. Advances in pharmacology (San Diego, Calif.),
82, 85-102. doi:10.1016/bs.apha.2017.09.001
Galagan, J. E., Calvo, S. E., Borkovich, K. A., Selker, E. U., Read, N. D., Jaffe, D.,
FitzHugh, W., Ma, L. J., Smirnov, S., Purcell, S., Rehman, B., Elkins, T., Engels,
R., Wang, S., Nielsen, C. B., Butler, J., Endrizzi, M., Qui, D., Ianakiev, P., BellPedersen, D., Nelson, M. A., Werner-Washburne, M., Selitrennikoff, C. P.,
Kinsey, J. A., Braun, E. L., Zelter, A., Schulte, U., Kothe, G. O., Jedd, G.,
Mewes, W., Staben, C., Marcotte, E., Greenberg, D., Roy, A., Foley, K., Naylor,
J., Stange-Thomann, N., Barrett, R., Gnerre, S., Kamal, M., Kamvysselis, M.,
Mauceli, E., Bielke, C., Rudd, S., Frishman, D., Krystofova, S., Rasmussen, C.,
Metzenberg, R. L., Perkins, D. D., Kroken, S., Cogoni, C., Macino, G.,
Catcheside, D., Li, W., Pratt, R. J., Osmani, S. A., DeSouza, C. P., Glass, L.,
Orbach, M. J., Berglund, J. A., Voelker, R., Yarden, O., Plamann, M., Seiler, S.,
Dunlap, J., Radford, A., Aramayo, R., Natvig, D. O., Alex, L. A., Mannhaupt, G.,
Ebbole, D. J., Freitag, M., Paulsen, I., Sachs, M. S., Lander, E. S., Nusbaum, C.,
& Birren, B. (2003). The genome sequence of the filamentous fungus Neurospora
crassa. Nature, 422(6934), 859-868. doi:10.1038/nature01554
Goffeau, A., Barrell, B. G., Bussey, H., Davis, R. W., Dujon, B., Feldmann, H., Galibert,
F., Hoheisel, J. D., Jacq, C., Johnston, M., Louis, E. J., Mewes, H. W., Murakami,
Y., Philippsen, P., Tettelin, H., & Oliver, S. G. (1996). Life with 6000 genes.
Science, 274(5287), 546, 563-547. doi:10.1126/science.274.5287.546
Gomis-Ruth, F. X. (2008). Structure and mechanism of metallocarboxypeptidases. Crit
Rev Biochem Mol Biol, 43(5), 319-345. doi:10.1080/10409230802376375
Goodwin, S., Gurtowski, J., Ethe-Sayers, S., Deshpande, P., Schatz, M. C., &
McCombie, W. R. (2015). Oxford Nanopore sequencing, hybrid error correction,
and de novo assembly of a eukaryotic genome. Genome Res, 25(11), 1750-1756.
doi:10.1101/gr.191395.115
Greenblatt, E. J., Olzmann, J. A., & Kopito, R. R. (2011). Derlin-1 is a rhomboid
pseudoprotease required for the dislocation of mutant alpha-1 antitrypsin from the
endoplasmic reticulum. Nat Struct Mol Biol, 18(10), 1147-1152.
doi:10.1038/nsmb.2111
Greig, D., & Leu, J. Y. (2009). Natural history of budding yeast. Curr Biol, 19(19),
R886-890. doi:10.1016/j.cub.2009.07.037
Hancock, J. M., & Bishop, M. J. (2014). EMBOSS (The European Molecular Biology
Open Software Suite). Dictionary of Bioinformatics and Computational Biology.
doi:doi:10.1002/9780471650126.dob0206.pub2

128

Harrington, B. J., & Raper, K. B. (1968). Use of a fluorescent brightener to demonstrate
cellulose in the cellular slime molds. Applied microbiology, 16(1), 106-113.
Retrieved from https://pubmed.ncbi.nlm.nih.gov/5688830
Hawksworth, D., & Lücking, R. (2017). Fungal Diversity Revisited: 2.2 to 3.8 Million
Species. Microbiology Spectrum, 5. doi:10.1128/microbiolspec.FUNK-0052-2016
Herth, W., & Schnepf, E. (1980). The fluorochrome, calcofluor white, binds oriented to
structural polysaccharide fibrils. Protoplasma, 105(1), 129-133.
doi:10.1007/BF01279855
Hillenmeyer, M. E., Fung, E., Wildenhain, J., Pierce, S. E., Hoon, S., Lee, W., Proctor,
M., St Onge, R. P., Tyers, M., Koller, D., Altman, R. B., Davis, R. W., Nislow,
C., & Giaever, G. (2008). The chemical genomic portrait of yeast: uncovering a
phenotype for all genes. Science, 320(5874), 362-365.
doi:10.1126/science.1150021
Hinnen, A., Hicks, J. B., & Fink, G. R. (1978). Transformation of yeast. Proc Natl Acad
Sci U S A, 75(4), 1929-1933. doi:10.1073/pnas.75.4.1929
Hoffman, C. S., Wood, V., & Fantes, P. A. (2015). An Ancient Yeast for Young
Geneticists: A Primer on the Schizosaccharomyces pombe Model System.
Genetics, 201(2), 403-423. doi:10.1534/genetics.115.181503
Houbraken, J., Frisvad, J. C., & Samson, R. A. (2011). Fleming's penicillin producing
strain is not Penicillium chrysogenum but P. rubens. IMA Fungus, 2(1), 87-95.
doi:10.5598/imafungus.2011.02.01.12
Huh, W. K., Falvo, J. V., Gerke, L. C., Carroll, A. S., Howson, R. W., Weissman, J. S., &
O'Shea, E. K. (2003). Global analysis of protein localization in budding yeast.
Nature, 425(6959), 686-691. doi:10.1038/nature02026
Idowu, T. A., Schott, M. J., & Lyons, P. J. (2016). Characterization of Ecm14, a Fungal
Pseudopeptidase. The FASEB Journal, 30(S1), 596.597-596.597.
doi:10.1096/fasebj.30.1_supplement.596.7
Igarashi, R., Suzuki, M., Nogami, S., & Ohya, Y. (2005). Molecular dissection of ARP1
regions required for nuclear migration and cell wall integrity checkpoint functions
in Saccharomyces cerevisiae. Cell Struct Funct, 30(2), 57-67.
doi:10.1247/csf.30.57
Jeffery, C. J. (2003). Moonlighting proteins: old proteins learning new tricks. Trends
Genet, 19(8), 415-417. doi:10.1016/S0168-9525(03)00167-7
Joshi, L., & St Leger, R. J. (1999). Cloning, expression, and substrate specificity of
MeCPA, a zinc carboxypeptidase that is secreted into infected tissues by the
fungal entomopathogen Metarhizium anisopliae. J Biol Chem, 274(14), 98039811. doi:10.1074/jbc.274.14.9803
Jouhten, P., Ponomarova, O., Gonzalez, R., & Patil, K. R. (2016). Saccharomyces
cerevisiae metabolism in ecological context. FEMS Yeast Res, 16(7).
doi:10.1093/femsyr/fow080
Kalinina, E., Biswas, R., Berezniuk, I., Hermoso, A., Aviles, F. X., & Flicker, L. D.
(2007). A novel subfamily of mouse cytosolic carboxypeptidases. The FASEB
Journal, 21(3), 836-850. doi:10.1096/fj.06-7329com

129

Kearse, M., Moir, R., Wilson, A., Stones-Havas, S., Cheung, M., Sturrock, S., Buxton, S.,
Cooper, A., Markowitz, S., Duran, C., Thierer, T., Ashton, B., Meintjes, P., &
Drummond, A. (2012). Geneious Basic: an integrated and extendable desktop
software platform for the organization and analysis of sequence data.
Bioinformatics, 28(12), 1647-1649. doi:10.1093/bioinformatics/bts199
Kirk, P. M., Cannon, P. F., David, J. C., & Stalpers, J. A. (2001). Ainsworth and Bisby's
dictionary of the fungi: 9th edition. Wallingford: CABI Publishing.
Klis, F. M., Boorsma, A., & De Groot, P. W. (2006). Cell wall construction in
Saccharomyces cerevisiae. Yeast, 23(3), 185-202. doi:10.1002/yea.1349
Koshland, D., Kent, J. C., & Hartwell, L. H. (1985). Genetic analysis of the mitotic
transmission of minichromosomes. Cell, 40(2), 393-403. doi:10.1016/00928674(85)90153-9
Kwon, A., Scott, S., Taujale, R., Yeung, W., Kochut, K. J., Eyers, P. A., & Kannan, N.
(2019). Tracing the origin and evolution of pseudokinases across the tree of life.
Sci Signal, 12(578). doi:10.1126/scisignal.aav3810
Landvik, S., Schumacher, T., Eriksson, O., & Moss, S. (2003). Morphology and
ultrastructure of Neolecta species. Mycological research, 107, 1021-1031.
doi:10.1017/S0953756203008219
Lang, G. I., Parsons, L., & Gammie, A. E. (2013). Mutation rates, spectra, and genomewide distribution of spontaneous mutations in mismatch repair deficient yeast. G3
(Bethesda, Md.), 3(9), 1453-1465. doi:10.1534/g3.113.006429
Laurent, J. M., Young, J. H., Kachroo, A. H., & Marcotte, E. M. (2016). Efforts to make
and apply humanized yeast. Brief Funct Genomics, 15(2), 155-163.
doi:10.1093/bfgp/elv041
Leducq, J. B., Charron, G., Samani, P., Dube, A. K., Sylvester, K., James, B., Almeida,
P., Sampaio, J. P., Hittinger, C. T., Bell, G., & Landry, C. R. (2014). Local
climatic adaptation in a widespread microorganism. Proc Biol Sci, 281(1777),
20132472. doi:10.1098/rspb.2013.2472
Lemberg, M. K. (2011). Intramembrane proteolysis in regulated protein trafficking.
Traffic, 12(9), 1109-1118. doi:10.1111/j.1600-0854.2011.01219.x
Lesage, G., & Bussey, H. (2006). Cell wall assembly in Saccharomyces cerevisiae.
Microbiol Mol Biol Rev, 70(2), 317-343. doi:10.1128/MMBR.00038-05
Levine, B., Mizushima, N., & Virgin, H. W. (2011). Autophagy in immunity and
inflammation. Nature, 469(7330), 323-335. doi:10.1038/nature09782
Lezin, G., Kosaka, Y., Yost, H. J., Kuehn, M. R., & Brunelli, L. (2011). A one-step
miniprep for the isolation of plasmid DNA and lambda phage particles. PLOS
ONE, 6(8), e23457. doi:10.1371/journal.pone.0023457
Liu, W., Li, L., Ye, H., Chen, H., Shen, W., Zhong, Y., Tian, T., & He, H. (2017). From
Saccharomyces cerevisiae to human: The important gene co-expression modules.
Biomed Rep, 7(2), 153-158. doi:10.3892/br.2017.941
Looke, M., Kristjuhan, K., & Kristjuhan, A. (2011). Extraction of genomic DNA from
yeasts for PCR-based applications. Biotechniques, 50(5), 325-328.
doi:10.2144/000113672

130

Lussier, M., White, A. M., Sheraton, J., di Paolo, T., Treadwell, J., Southard, S. B.,
Horenstein, C. I., Chen-Weiner, J., Ram, A. F., Kapteyn, J. C., Roemer, T. W.,
Vo, D. H., Bondoc, D. C., Hall, J., Zhong, W. W., Sdicu, A. M., Davies, J., Klis,
F. M., Robbins, P. W., & Bussey, H. (1997). Large scale identification of genes
involved in cell surface biosynthesis and architecture in Saccharomyces
cerevisiae. Genetics, 147(2), 435-450. Retrieved from
https://www.ncbi.nlm.nih.gov/pubmed/9335584
Lyons, P. J., & Fricker, L. D. (2011). Carboxypeptidase O is a
glycosylphosphatidylinositol-anchored intestinal peptidase with acidic amino acid
specificity. The Journal of biological chemistry, 286(45), 39023-39032.
doi:10.1074/jbc.M111.265819
Magnelli, P., Cipollo, J. F., & Abeijon, C. (2002). A refined method for the determination
of Saccharomyces cerevisiae cell wall composition and beta-1,6-glucan fine
structure. Anal Biochem, 301(1), 136-150. doi:10.1006/abio.2001.5473
Martins, N., Ferreira, I. C., Barros, L., Silva, S., & Henriques, M. (2014). Candidiasis:
predisposing factors, prevention, diagnosis and alternative treatment.
Mycopathologia, 177(5-6), 223-240. doi:10.1007/s11046-014-9749-1
Matheson, K., Parsons, L., & Gammie, A. (2017). Whole-Genome Sequence and Variant
Analysis of W303, a Widely-Used Strain of Saccharomyces cerevisiae. G3
(Bethesda), 7(7), 2219-2226. doi:10.1534/g3.117.040022
Nagashima, M., Yin, Z. F., Broze, G. J., Jr., & Morser, J. (2002). Thrombin-activatable
fibrinolysis inhibitor (TAFI) deficient mice. Front Biosci, 7, d556-568. Retrieved
from https://www.ncbi.nlm.nih.gov/pubmed/11815293
Nagata, T., & Takebe, I. (1970). Cell wall regeneration and cell division in isolated
tobacco mesophyll protoplasts. Planta, 92(4), 301-308. doi:10.1007/BF00385097
Naggert, J. K., Fricker, L. D., Varlamov, O., Nishina, P. M., Rouille, Y., Steiner, D. F.,
Carroll, R. J., Paigen, B. J., & Leiter, E. H. (1995). Hyperproinsulinaemia in
obese fat/fat mice associated with a carboxypeptidase E mutation which reduces
enzyme activity. Nature Genetics, 10(2), 135-142. doi:10.1038/ng0695-135
Neiman, A. M. (2005). Ascospore formation in the yeast Saccharomyces cerevisiae.
Microbiol Mol Biol Rev, 69(4), 565-584. doi:10.1128/MMBR.69.4.565-584.2005
Neiman, A. M. (2011). Sporulation in the budding yeast Saccharomyces cerevisiae.
Genetics, 189(3), 737-765. doi:10.1534/genetics.111.127126
Nguyen, T. H., Fleet, G. H., & Rogers, P. L. (1998). Composition of the cell walls of
several yeast species. Applied Microbiology and Biotechnology, 50(2), 206-212.
doi:10.1007/s002530051278
Nijman, S. M. (2011). Synthetic lethality: general principles, utility and detection using
genetic screens in human cells. FEBS Lett, 585(1), 1-6.
doi:10.1016/j.febslet.2010.11.024
Noda-Garcia, L., & Barona-Gomez, F. (2013). Enzyme evolution beyond gene
duplication: A model for incorporating horizontal gene transfer. Mob Genet
Elements, 3(5), e26439. doi:10.4161/mge.26439
Ohno, S. (1970). Evolution by gene duplication. London, New York,: Allen & Unwin;
Springer-Verlag.

131

Okonechnikov, K., Golosova, O., Fursov, M., & the, U. t. (2012). Unipro UGENE: a
unified bioinformatics toolkit. Bioinformatics, 28(8), 1166-1167.
doi:10.1093/bioinformatics/bts091
Oliver, S. G., van der Aart, Q. J., Agostoni-Carbone, M. L., Aigle, M., Alberghina, L.,
Alexandraki, D., Antoine, G., Anwar, R., Ballesta, J. P., Benit, P., & et al. (1992).
The complete DNA sequence of yeast chromosome III. Nature, 357(6373), 38-46.
doi:10.1038/357038a0
Otazo, M. R. d. l. V., Lorenzo, J., Tort, O., Avilés, F. X., & Bautista, J. M. (2013).
Functional segregation and emerging role of cilia-related cytosolic
carboxypeptidases (CCPs). The FASEB Journal, 27(2), 424-431.
doi:10.1096/fj.12-209080
Parzych, K. R., Ariosa, A., Mari, M., & Klionsky, D. J. (2018). A newly characterized
vacuolar serine carboxypeptidase, Atg42/Ybr139w, is required for normal vacuole
function and the terminal steps of autophagy in the yeast Saccharomyces
cerevisiae. Mol Biol Cell, 29(9), 1089-1099. doi:10.1091/mbc.E17-08-0516
Pascual, R., Burgos, F. J., Salva, M., Soriano, F., Mendez, E., & Aviles, F. X. (1989).
Purification and properties of five different forms of human
procarboxypeptidases. Eur J Biochem, 179(3), 609-616. doi:10.1111/j.14321033.1989.tb14590.x
Peter, J., De Chiara, M., Friedrich, A., Yue, J. X., Pflieger, D., Bergstrom, A., Sigwalt,
A., Barre, B., Freel, K., Llored, A., Cruaud, C., Labadie, K., Aury, J. M., Istace,
B., Lebrigand, K., Barbry, P., Engelen, S., Lemainque, A., Wincker, P., Liti, G.,
& Schacherer, J. (2018). Genome evolution across 1,011 Saccharomyces
cerevisiae isolates. Nature, 556(7701), 339-344. doi:10.1038/s41586-018-0030-5
Petrera, A., Lai, Z. W., & Schilling, O. (2014). Carboxyterminal protein processing in
health and disease: key actors and emerging technologies. J Proteome Res,
13(11), 4497-4504. doi:10.1021/pr5005746
Pfaller, M. A., & Diekema, D. J. (2007). Epidemiology of invasive candidiasis: a
persistent public health problem. Clinical microbiology reviews, 20(1), 133-163.
doi:10.1128/CMR.00029-06
Pils, B., & Schultz, J. (2004). Inactive enzyme-homologues find new function in
regulatory processes. J Mol Biol, 340(3), 399-404. doi:10.1016/j.jmb.2004.04.063
Pink, R. C., Wicks, K., Caley, D. P., Punch, E. K., Jacobs, L., & Carter, D. R. (2011).
Pseudogenes: pseudo-functional or key regulators in health and disease? RNA,
17(5), 792-798. doi:10.1261/rna.2658311
Popolo, L., Gualtieri, T., & Ragni, E. (2001). The yeast cell-wall salvage pathway. Med
Mycol, 39 Suppl 1, 111-121. Retrieved from
https://www.ncbi.nlm.nih.gov/pubmed/11800265
Ralser, M., Kuhl, H., Ralser, M., Werber, M., Lehrach, H., Breitenbach, M., &
Timmermann, B. (2012). The Saccharomyces cerevisiae W303-K6001 crossplatform genome sequence: insights into ancestry and physiology of a laboratory
mutt. Open biology, 2(8), 120093-120093. doi:10.1098/rsob.120093
Ram, A. F. J., Wolters, A., Hoopen, R. T., & Klis, F. M. (1994). A new approach for
isolating cell wall mutants in Saccharomyces cerevisiae by screening for
hypersensitivity to calcofluor white. Yeast, 10(8), 1019-1030.
doi:10.1002/yea.320100804
132

Rawlings, N. D., Barrett, A. J., Thomas, P. D., Huang, X., Bateman, A., & Finn, R. D.
(2018). The MEROPS database of proteolytic enzymes, their substrates and
inhibitors in 2017 and a comparison with peptidases in the PANTHER database.
Nucleic Acids Res, 46(D1), D624-D632. doi:10.1093/nar/gkx1134
Reiterer, V., Eyers, P. A., & Farhan, H. (2014). Day of the dead: pseudokinases and
pseudophosphatases in physiology and disease. Trends Cell Biol, 24(9), 489-505.
doi:10.1016/j.tcb.2014.03.008
Reznik, S. E., & Fricker, L. D. (2001). Carboxypeptidases from A to z: implications in
embryonic development and Wnt binding. Cell Mol Life Sci, 58(12-13), 17901804. doi:10.1007/PL00000819
Ribeiro, A. J. M., Das, S., Dawson, N., Zaru, R., Orchard, S., Thornton, J. M., Orengo,
C., Zeqiraj, E., Murphy, J. M., & Eyers, P. A. (2019). Emerging concepts in
pseudoenzyme classification, evolution, and signaling. Sci Signal, 12(594).
doi:10.1126/scisignal.aat9797
Roncero, C., & Duran, A. (1985). Effect of Calcofluor white and Congo red on fungal
cell wall morphogenesis: in vivo activation of chitin polymerization. J Bacteriol,
163(3), 1180-1185. doi:10.1128/JB.163.3.1180-1185.1985
Ruderfer, D. M., Pratt, S. C., Seidel, H. S., & Kruglyak, L. (2006). Population genomic
analysis of outcrossing and recombination in yeast. Nat Genet, 38(9), 1077-1081.
doi:10.1038/ng1859
Rueden, C. T., Schindelin, J., Hiner, M. C., DeZonia, B. E., Walter, A. E., Arena, E. T.,
& Eliceiri, K. W. (2017). ImageJ2: ImageJ for the next generation of scientific
image data. BMC Bioinformatics, 18(1), 529. doi:10.1186/s12859-017-1934-z
Sadowski, I., Lourenco, P., & Parent, J. (2008). Dominant marker vectors for selecting
yeast mating products. Yeast, 25(8), 595-599. doi:10.1002/yea.1604
Schoner, D., Kalisch, M., Leisner, C., Meier, L., Sohrmann, M., Faty, M., Barral, Y.,
Peter, M., Gruissem, W., & Buhlmann, P. (2008). Annotating novel genes by
integrating synthetic lethals and genomic information. BMC Syst Biol, 2, 3.
doi:10.1186/1752-0509-2-3
Schott, M. J. (2015). Expression and Characterization of ECM14, a
Metallocarboxypeptidase from Saccharomyces Cerevisiae. Master's Theses, 88.
Retrieved from https://digitalcommons.andrews.edu/theses/88/
Smith, M. L., Bruhn, J. N., & Anderson, J. B. (1992). The fungus Armillaria bulbosa is
among the largest and oldest living organisms. Nature, 356(6368), 428-431.
doi:10.1038/356428a0
Somerville, C., Bauer, S., Brininstool, G., Facette, M., Hamann, T., Milne, J., Osborne,
E., Paredez, A., Persson, S., Raab, T., Vorwerk, S., & Youngs, H. (2004). Toward
a systems approach to understanding plant cell walls. Science, 306(5705), 22062211. doi:10.1126/science.1102765
Song, G., Dickins, B. J. A., Demeter, J., Engel, S., Gallagher, J., Choe, K., Dunn, B.,
Snyder, M., & Cherry, J. M. (2015). Correction: AGAPE (Automated Genome
Analysis PipelinE) for Pan-Genome Analysis of Saccharomyces cerevisiae. PLOS
ONE, 10(5), e0129184-e0129184. doi:10.1371/journal.pone.0129184

133

Spatafora, J., Sung, G.-H., Johnson, D., Hesse, C., O'Rourke, B., Serdani, M., Spotts, R.,
Lutzoni, F., Valerie, H., Miadlikowska, J., Reeb, V., Gueidan, C., Fraker, E.,
Lumbsch, T., Lücking, R., Schmitt, I., Hosaka, K., Aptroot, A., Roux, C., &
Schoch, C. (2006). A five-gene phylogeny of Pezizomycotina. Mycologia, 98,
1018-1028. doi:10.3852/mycologia.98.6.1018
Sugiyama, J., Hosaka, K., & Suh, S. O. (2006). Early diverging Ascomycota:
phylogenetic divergence and related evolutionary enigmas. Mycologia, 98(6),
996-1005. doi:10.3852/mycologia.98.6.996
Tan, F., Morris, P., Skidgel, R., & Erdös, E. (1993). Sequencing and cloning of human
prolylcarboxypeptidase (Angiotensinase C). Similarity to both serine
carboxypeptidase and prolylendopeptidase families. The Journal of biological
chemistry, 268, 16631-16638.
Wach, A., Brachat, A., Pöhlmann, R., & Philippsen, P. (1994). New heterologous
modules for classical or PCR-based gene disruptions in Saccharomyces
cerevisiae. Yeast, 10(13), 1793-1808. doi:10.1002/yea.320101310
Wenger, R. M. (1984). Synthesis of cyclosporine. Total syntheses of ‘cyclosporin A’ and
‘cyclosporin H’, two fungal metabolites isolated from the species Tolypocladium
inflatum GAMS. Helvetica Chimica Acta, 67(2), 502-525.
doi:10.1002/hlca.19840670220
Wiederhold, E., Gandhi, T., Permentier, H. P., Breitling, R., Poolman, B., & Slotboom,
D. J. (2009). The yeast vacuolar membrane proteome. Mol Cell Proteomics, 8(2),
380-392. doi:10.1074/mcp.M800372-MCP200
Winston, F. (2008). EMS and UV Mutagenesis in Yeast. Current Protocols in Molecular
Biology, 82(1), 13.13B.11-13.13B.15. doi:10.1002/0471142727.mb1303bs82
Winzeler, E. A., Shoemaker, D. D., Astromoff, A., Liang, H., Anderson, K., Andre, B.,
Bangham, R., Benito, R., Boeke, J. D., Bussey, H., Chu, A. M., Connelly, C.,
Davis, K., Dietrich, F., Dow, S. W., El Bakkoury, M., Foury, F., Friend, S. H.,
Gentalen, E., Giaever, G., Hegemann, J. H., Jones, T., Laub, M., Liao, H.,
Liebundguth, N., Lockhart, D. J., Lucau-Danila, A., Lussier, M., M'Rabet, N.,
Menard, P., Mittmann, M., Pai, C., Rebischung, C., Revuelta, J. L., Riles, L.,
Roberts, C. J., Ross-MacDonald, P., Scherens, B., Snyder, M., Sookhai-Mahadeo,
S., Storms, R. K., Veronneau, S., Voet, M., Volckaert, G., Ward, T. R., Wysocki,
R., Yen, G. S., Yu, K., Zimmermann, K., Philippsen, P., Johnston, M., & Davis,
R. W. (1999). Functional characterization of the S. cerevisiae genome by gene
deletion and parallel analysis. Science, 285(5429), 901-906.
doi:10.1126/science.285.5429.901
Yang, Z., Huang, J., Geng, J., Nair, U., & Klionsky, D. J. (2006). Atg22 recycles amino
acids to link the degradative and recycling functions of autophagy. Mol Biol Cell,
17(12), 5094-5104. doi:10.1091/mbc.e06-06-0479
Zaugg, C., Jousson, O., Lechenne, B., Staib, P., & Monod, M. (2008). Trichophyton
rubrum secreted and membrane-associated carboxypeptidases. Int J Med
Microbiol, 298(7-8), 669-682. doi:10.1016/j.ijmm.2007.11.005
Zettl, M., Adrain, C., Strisovsky, K., Lastun, V., & Freeman, M. (2011). Rhomboid
family pseudoproteases use the ER quality control machinery to regulate
intercellular signaling. Cell, 145(1), 79-91. doi:10.1016/j.cell.2011.02.047
134

Zhang, X., Cheng, W., Feng, Z., Zhu, Q., Sun, Y., Li, Y., & Sun, J. (2020).
Transcriptomic analysis of gene expression of Verticillium dahliae upon treatment
of the cotton root exudates. BMC Genomics, 21(1), 155. doi:10.1186/s12864-0206448-9
Zörgö, E., Chwialkowska, K., Gjuvsland, A. B., Garré, E., Sunnerhagen, P., Liti, G.,
Blomberg, A., Omholt, S. W., & Warringer, J. (2013). Ancient Evolutionary
Trade-Offs between Yeast Ploidy States. PLOS Genetics, 9(3), e1003388.
doi:10.1371/journal.pgen.1003388

135

